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If I have seen further it is by standing on the shoulders of giants. 























































In this study I aim to evaluate how the actin binding protein filamin B influences the 
development of cartilaginous structures of the skeleton, that when mutated, causes a range 
of disorders impacting large joints, limb development and craniofacial aspects of the body. 
Joints are an essential part of any organism as they allow for movement and are therefore 
extremely complex mechanical structures. The soft tissue elements of the joints are 
important because they provide these joints the ability to withstand immense forces from 
movement. Little is known about how filamin B is involved in the formation of the soft tissues 
in the developing joint and therefore the lack of understanding of how filamin B variants lead 
to the dislocation of the large joints seen in Larsen syndrome and other filamin B related 
syndromes. Joint development is critical in analysing how filamin B is involved in the 
formation and rare disease are an extremely valuable tool in approaching this. Rare genetic 
diseases such as Atelosteogenesis types I (AOI), Atelosteogenesis type III (AOIII), Boomerang 
dysplasia (BD) Spondylocarpotarsal synostosis syndrome (SCTS) and Larsen syndrome (LS) can 
all show different aspects of development that has been disrupted from various mutations 
within the filamin B gene. These are able to provide indications on what section of the filamin 
B protein, then when perturbed, leads to developmental abnormalities. In this study I used 
two mouse models tagged with the fluorophore mCherry and eGFP to track the development 
of joints in mice, in relation to filamin B both with and without the protein’s hinge-1. 
My research found that both forms of hinge-1 included filamin B and hinge-1 excluded filamin 
B are found during development. It was also shown that red puncta indicating hinge-1 
excluded filamin B is present within the joint capsule between the forming femur and tibia at 
E15.5. These red puncta were observed in the cells adjacent to the cellular membrane. During 
development the red puncta were exclusively defined to the joint spaces within all developing 
legs examined at E15.5. It was also shown that the critical point for knee joint ligament 
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1 Joint development 
 
1.1 Development and structure of the knee joint 
Connective tissues are an essential part of any organ system in the body and provide essential 
structural support (Mansour, 2003). There are many syndromes associated with changes in 
these connective tissues that result in a wide range of disorders. These include structural 
abnormalities of the connective fibres of the skin, vascular structures, joints, tendons and 
ligaments (Hermanns et al., 2008). Careful examination of these structures during 
development has been essential for understanding how these structures are affected in 
genetic disorders. In particular the connective tissues of the joints are a complex and exciting 
area of developmental biology. These areas are highly reliant on correct modelling of 
cartilaginous tissue, in order to be able to withstand extreme levels of force relative to their 
small size (Mansour, 2003).  
 
The particular focus of this research is the connective tissues of the capsule surrounding the 
knee joint; particularly the ligaments and menisci of the joint, as it is not currently fully 
understood how these structures are formed. The knee joint is supported by a series of 
ligaments holding the two bones (femur and tibia) together. The ligamentous structures of 
the knee are the lateral and medial collateral ligaments (LCL, MCL),  and the anterior and 
posterior cruciate ligaments (ACL, PCL) (Rumian et al., 2007). Together these ligaments 
stabilise the joint and enable it to withstand the mechanical forces allowing it to resist 
transverse movement. 
 
I hypothesise that the joint dislocations found in Larsen syndrome occur due to some defect 
in the surrounding soft tissues of these joints that would typically provide stability to them as 
the bones of these joints, in particular, the metaphyses and diaphyses of the long bones, 





Figure 1.1: Mouse limb development and knee anatomy 
A, A simplified diagram showing the development of mouse fore and hind limbs, the upper 
limbs begin to develop before the legs. Adapted from (Limb Development - Embryology, n.d.). 
Cartilage is shown in blue; bone in black. 
B. Diagram showing the ligaments within the knee viewed for the ventral aspect, adapted 
from (Cimino et al., 2010). 
C. Schematic representations of the morphological changes occurring during forelimb bud 
development (E9.5-E16.5). Hindlimb bud development (not shown) is delayed by half a day 
in comparison with the forelimb bud. Skeletal elements are depicted as they appear when 
stained with Alcian Blue (to highlight mature cartilage) and Alizarin Red (to highlight 
mineralised bone). Adapted from (Zuniga, 2015) 
 
1.1.1 Ligaments 
Ligaments are dense fibrous structures that connect bone to bone, providing vital support to 
a joint. The knee joint has four major ligamentous structures; these are the lateral and medial 
collateral ligaments (LCL, MCL) appearing as the two grey structures located peripherally in 
Figure 1.1B and anterior and posterior cruciate ligament (ACL, PCL respectively) (Rumian et 
al., 2007) shown in the centre of the knee joint in Figure 1.1B.  
 
These ligaments are an extremely important structural element of the knee joint as they 
provide the majority of rotational resistance (Duthon et al., 2006). The cruciate ligaments (CL) 
are made of a strong and complex extracellular matrix and have a microstructure that consists 
mostly of collagen type I, along with a matrix of proteins such as glycoproteins, elastic fibres 
and glycosaminoglycans. This complex organisation of these structures forms a robust tissue 
allowing the CL to resist tearing under a range of multi-axis stresses and tensile strain (Duthon 
 3 
et al., 2006). The ACL has an average length of 32mm and a width of 7-12mm in humans. The 
ACL is connected to the vascular system by small vessels that lead to the middle genicular 
artery (Duthon et al., 2006).  
 
It is thought that the ACL originates from the mesenchyme. This formation precedes the 
formation of the joint capsule. Duthon et al. 2006, described the forming ligament as being 
surrounded by a mesentery-like fold of synovium that originates from the posterior region of 
the joint capsule apparatus of the knee joint, while the ACL is located within the knee joint 
capsule itself. It remains extra-synovial throughout its course of development (Ellison & Berg, 
1985).  
 
1.1.2 Meniscus  
The meniscus is a disk-shaped piece of cartilage that forms a cushion between the tibia and 
femur. It consists of two main portions, the inner and the outer.  The cells of the menisci are 
referred to as fibrochondrocytes because they appear to be a mixture of fibroblasts and 
chondrocytes (Kahn et al., 2009). In adulthood, the meniscus is a relatively avascular fibrous 
tissue with few cells and a limited blood supply (Fox et al., 2012). Because of this, injuries that 
affect the menisci are difficult to treat and require a prolonged time to heal. Long term 
damage may lead to degenerative joint changes such as osteophyte formation, articular 
cartilage degeneration, joint space narrowing and symptomatic osteoarthritis (Kusayama et 
al., 1994). 
 
The meniscus begins as a highly cellular mass with a high vascular presence compared to 
those in an adult. However, as development progresses the number of cells within each 
meniscus gradually decreases. As this is occurring, space is made for the increasing matrix of 
collagen fibres that begin to take the shape of the menisci. After these structures are 
established, movement of the joint and the impact of weight-bearing stress are crucial. This 
allows for proper collagen fibre orientation leading to the best possible mechanical stress 




In a fully developed human meniscus, two cell populations, fibroblast-like and 
fibrochondrocytes, can be seen, the inner and middle section consisting of one type, 
fibrochondrocytes and the outer consisting of	fibroblast-like cells (Verdonk et al., 2005).  
The cell type of the inner and middle region appears round or oval-shaped and is surrounded 
by large amounts of ECM. This is where type II collagen makes up the majority of the fibrillar 
collagen. The outer section of the meniscus (the remaining ~33%) is constructed from 
fibroblast-like cells immersed in a dense connective tissue and this is primarily made of type 
I collagen. The outer section of the meniscus also contains vascular tissue that can be used to 
define the outer section (Verdonk et al., 2005). 
 
1.1.3 Joint development disruption pathologies  
A large number of developmental syndromes are attributed to structural abnormalities of the 
bone and supporting tissues. This could be because of deleterious changes in proteomic 
components of connective tissue or cartilage, causing a reduction in stress tolerance of these 
tissues (Hakim & Grahame, 2003). In humans, developmental pathways can be studied by the 
examination of some syndromes where these developmental pathways have been perturbed.  
In some cases, these syndromes can be produced by a single mutation in a key gene (Driver 
et al., 2020). At a molecular level, developmental disorders arise from a variety of factors that 
may be caused by gain or loss of function variants in a protein. These variants may perturb its 
role in complex protein structures or signalling pathways or both.  
 
 
1.2 The filamin B pathologies 
There are several syndromes resulting in joints abnormalities that are all a result of mutations 
in FLNB. A loss of function mutation is a variation (base(s) change in the DNA sequence) within 
the gene resulting in loss of function in a protein (Griffiths et al., 2000). A gain of function 
mutation in a gene is a variant within the gene that results in a new function of the protein or 
pathway the gene operates in (Griffiths et al., 2000). This can be seen in various syndromes; 
for example, in FLNB, depending on where the mutation occurs, a wide spectrum of skeletal 
dysplasias can be observed (Dodé et al., 2003). 
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Both gain of function and loss of function syndromes are an interesting aspect of clinical 
medicine as each one provides the opportunity to discover how a protein functions in the 
human body. There are a small number of these syndromes that are associated with FLNB. 
These will be covered in more detail in later sections. However, there is a range in severity 
from lethal forms such as Atelosteogenesis types I (AOI), Atelosteogenesis type III (AOIII) and 
boomerang dysplasia (BD) to a milder spectrum of phenotypes seen in spondylocarpotarsal 
synostosis syndrome (SCTS) and Larsen syndrome (LS). The developmental syndrome of 
particular interest in this study is Larsen syndrome. This syndrome is caused by mutations in 
FLNB, which encodes the protein, filamin B. 
 
1.2.1 Larsen syndrome  
The most common syndrome associated with pathogenic variants in FLNB is Larsen syndrome, 
an autosomal dominant gain of function disorder (Girisha et al., 2016a). A common 
phenotype observed in Larsen syndrome is the dislocation of large joints; however, there are 
other notable phenotypes. This syndrome has historically been described as an 
osteochondrodysplasia (Bicknell et al., 2007). This has been observed as presenting with 
dislocation of hips, elbows and, of particular interest to this project, the knees. However, as 
with many genetic conditions, Larsen is a syndrome has a recognisable series of phenotypes 
in addition to large joint dislocations. Other abnormalities can also be observed in the spine, 
fingers and some individuals can present with club feet (Figure 1.2).  
 
In more recent years and with the help of more modern techniques, such as genome 
sequencing and data sharing between clinics and lab groups, it is becoming apparent that 
Larsen syndrome, currently described as a congenital skeletal dysplasia may not be the best 
description. This is because this term does not appreciate the full phenotypic extent of the 
condition if, in fact the joint dislocations are a result of soft tissue abnormalities and not bone 
malformations, as the bones appear relatively normal compared to AOI and AOIII. 
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Figure 1.2: Larsen syndrome phenotypes 
A abnormalities in the cervical spine in Larsen syndrome showing cervical kyphosis 
complicated by cord compression and myelopathy shown by the arrow. B shows cervical 
kyphosis of a patient with Larsen syndrome. C shows bilateral knee dislocation and bilateral 
club feet and D shows bilateral elbow dislocation. E shows a more severe skeletal 
malformation, such as a distally tapering humerus often seen in Individuals with an overlap 
of Larsen syndrome and atelosteogenesis type III. F shows bilateral knee dislocations and J 
shows absent patella and dislocated knee. G & H show vertebral fusion and failure of fusion 
of the posterior neural arch. I shows elbow dislocation. L, M, N and K are clinical images 
from individuals with Larsen syndrome showing spatulate digits. L, M and N are of the hands 
and K is of the feet. O & P show shortening and broadening of the distal phalanges, most 
notable in the thumb. Supernumerary carpal bones and a bifid calcaneal ossification centre 
are commonly observed. Images adapted from (Bicknell et al., 2007; Girisha et al., 2016). 
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With reference to Figure 1.2, the phenotypic features in Larsen syndrome can vary 
significantly between individuals.  This is most notable in the large joints seen in the Figure 
1.2, where knee dislocation is shown in panels C, D, F and J, whereas in the panel I, elbow 
dislocation is also observed. The hips are also commonly dislocated but these are not shown 
here. The dislocations are commonly seen in both the hips and knees and this is most likely 
due to their weight-bearing nature.  Dislocations of the elbow have also been reported, 
however this joint is less commonly dislocated in this syndrome, most likely due to less 
physical stress being placed on the joint. The elbow has the 3rd highest rate of dislocation in 
Larsen syndrome - 65% of cases examined (Bicknell et al., 2007). 
 
While bone phenotypes are common in FLNB disorders such as AOI, AOIII and BD, a milder 
pathology is observed in the bones of Larsen patients. In addition to the large joint 
dislocations other primary phenotypic features include curvature of the cervical spine - 
scoliosis (sideways curvature of the spine) and kyphosis (where the cervical vertebrae have 
an inward curve from the sagittal plane, Figure 1.2 panel A). Cervical kyphosis was often found 
in these individuals and frequently in junction with subluxation or fusion of the C2–C3–C4 
vertebra (Bicknell et al., 2007; Krakow et al., 2004).  Other pathological features include 
craniofacial abnormalities, for example, an increased space between the eyes 
(hypertelorism), a prominent forehead, flattened midface and nasal bridge and, in some 
cases, a cleft palate, tapering of the long bones such as the humerus (Bicknell et al., 2007). 
The feet and hands can also be affected with spatulate-shaped digits which are most obvious 
in the thumb. Clubfeet and a short stature are also features seen in over half of cases while 
hearing loss has also been documented as a common complication (Bicknell et al., 2007; 
Girisha et al., 2016; Hermanns et al., 2008; Winer et al., 2009). Failure of fusion of the 
posterior neural arch have also been observed in some cases of Larsen syndrome; it was 
reported that 10 of the 16 individuals examined had spinal abnormalities (Bicknell et al., 
2007).  
 
Historically it has been considered that the abnormalities seen in bone development shown 
in these syndromes caused these joint dislocations. However, because the long bones appear 
mostly normal, we hypothesised that in the case of Larsen syndrome these joint pathologies 
originate from abnormal soft tissue development or soft tissue stability within the joint itself 
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that resulted in the instability of the joints. In particular, I hypothesised that it is the ligaments 
that hold the joint together and the stability provided by the meniscus is compromised by the 
mutations seen in FLNB. A more in-depth study of the soft tissues surrounding these major 
joints is needed to understand the underlying pathology of these disorders.  
 
1.2.2 Associated Filamin disorders  
With the exception of Spondylocarpotarsal synostosis syndrome (SCTS), the other filamin 
disorders (including Larsen syndrome) are a result of gain of function mutations within the 
coding sequencing of FLNB. SCTS is a knock-out of FLNB, meaning that both alleles are null 
(Robertson, 2020). 
 
The range of characteristics are observed in BD, AOI, LS and AOIII exist on a spectrum of 
severity. The most severe syndrome of BD and AOI, being lethal. To the less severe 
syndromes, such as AOIII which show under-ossified bones and joint dislocations, which are 
sometimes survivable, compared to the least severe Larsen syndrome that presents with joint 
dislocations and mild craniofacial abnormalities (Bicknell et al., 2007). AOIII is still relatively 
severe and can be fatal although in some cases it is survivable. These disorders result from 
either Indels (insertions and/or deletions) or missense variants in FLNB.  
 
1.2.2.1 Atelosteogenesis type 1 (AOI) 
Atelosteogenesis type 1 (AOI) is an autosomal dominant syndrome, caused by missense 
variants in FLNB and is a lethal skeletal dysplasia (Farrington-Rock et al., 2006) which affects 
bone development. AOI is more severe than AO type III and is a severe dwarfing condition 
that is lethal early in the prenatal period. However, AOI has similar phenotypes to that of 
Larsen (Table 1.1), wherein the phenotypes of clubfeet are often present and so are 
dislocations of the hips, knees and elbows. The difference between these syndromes is more 
notable when taking a wider examination of the skeleton as the bones of the rib cage, pelvis, 
upper and lower limbs are underdeveloped. It is these affected areas of the skeleton that 
usually result in foetal death. In addition, there are some rarer cases where these bones can 
appear to be missing altogether (Farrington-Rock et al., 2006; Wessels et al., 2011). As the 
lungs are often severely affected a result of the underdeveloped rib cage this results in 
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neonatal lethality (Farrington-Rock et al., 2006; Wessels et al., 2011). There are also facial 
abnormalities such as a misshapen nose, reduced lower jaw, chin size, increased eye spacing 
and a prominent or protruding forehead. A cleft palate has also been associated with this 
disorder (Farrington-Rock et al., 2006; Sillence et al., 1997; Wessels et al., 2011). 
 
1.2.2.2 Atelosteogenesis type III (AOIII) 
Atelosteogenesis type III (AOIII), also affects bone development but is milder compared to 
AOI. Most features are similar to AOI and are outlined in table 1. Like AOI, these individuals 
do have an underdeveloped ribcage and therefore lung development and function is 
impaired. However, although some affected individuals die in the perinatal period, due to 
respiratory failure, there are cases of individuals surviving longer with extensive medical 
intervention (Farrington-Rock et al., 2006; Stern et al., 1990; Wessels et al., 2011). 
 
Both Atelosteogenesis type 1 (AOI) and Atelosteogenesis type 3 (AOIII) are autosomal 
dominant disorders and are the result of de novo mutations (new mutations). This means that 
new cases of this disorder are not inherited and will almost always occur in families with no 
previous history of this disorder. 
 
1.2.2.3 Boomerang dysplasia (BS) 
Boomerang dysplasia (BS) is a lethal osteochondrodysplasia. As with AOI, AOIII and Larsen 
syndrome, phenotypic features can include club feet, dislocations of the knee, elbow and hips 
(Winship et al., 1990). The bones of the ribs, pelvis, upper and lower limbs may be 
underdeveloped or absent (Table 1.1). Due to the defective development of the bones, 
affected individuals with this dysplasia have very short arms and legs. A particularly notable 
phenotype of this dysplasia is a pronounced bowing of the femur producing the boomerang 
shape (Bicknell et al., 2005; Winship et al., 1990). 
 
In addition to pulmonary complications due to ribcage abnormalities, an associated feature 
is an opening in the abdominal wall allowing the protrusion of some organs (omphalocele). 
Boomerang dysplasia has only around ten recorded cases (Bicknell et al., 2005). 
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1.2.2.4 Spondylocarpotarsal synostosis syndrome (SCTS) 
Spondylocarpotarsal synostosis syndrome (SCTS) is an autosomal recessive disorder which 
can be produced by biallelic mutations in FLNB (Cameron-Christie et al., 2018; Coêlho et al., 
1998; Sawyer et al., 2009). SCTS is characterised by the fusion of the vertebrae though 
ossification of the intervening intervertebral discs. Individuals affected with this syndrome 
have short stature, disproportionately short mid-body, lordosis and/or scoliosis, cleft palate, 
reduced or loss of hearing and enamel hypoplasia (Table 1.1) (Farrington-Rock et al., 2008; 
Isidor et al., 2008; Yang et al., 2017). Joint laxity has also been noted, (Krakow et al., 2004b; 
Langer et al., 1994). 
  
SCTS is produced by a loss of function of filamin B, meaning when looking at experiments and 
models to analyse how filamin B deficiency may produce these phenotypes, SCTS can provide 
an indication of what cells and tissues look like without filamin B protein expression. In a study 
done on a Flnb knockout mouse model,  Zhou et al. 2007 found that not only did homozygous 
Flnb knockouts have a very low postnatal survival rate (3%) but also that the heterozygotes 
appeared normal with no difference compared to their wild-type siblings. Homozygotes were 
very small and had severe skeletal malformations that closely resembled the phenotypes seen 
in humans with mutations in FLNB.   
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Clinical similarities between Atelosteogenesis type I, Atelosteogenesis type III, Boomerang, Larsen and Spondylocarpotarsal synostosis 
 
Table 1.1: Clinical similarities between Atelosteogenesis type I, Atelosteogenesis type III, Boomerang, Larsen and Spondylocarpotarsal synostosis 
Summary of  phenotypic features seen in Atelosteogenesis type I, Atelosteogenesis type III, Boomerang, Larsen and Spondylocarpotarsal 
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Larsen Syndrome + +++ + ++ ++ ++ + + + + + +++ + +++ +++ +++ +++   +++ 
Atelosteogenesis 
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                  +++ +++     + + + ++ +++ + 
Atelosteogenesis 
Type 3  
++       ++         +     +++ ++ ++ ++ + + +++ 
Boomerang 
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  + + ++   +++ +++ +++                 +   + 
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1.2.3 FLNB variants  
The filamin B syndromes discussed, AOI, AOIII, BD and Larsen syndrome can be inherited in 
an autosomal dominant pattern. But as some of these are quite severe and these syndromes 
often arise de novo or in some extraordinary cases, a mosaic individual can carry a mutation 
and transmit it while remaining mildly affected themselves. Causative pathogenic variants in 
FLNB are found in clusters depending on the syndrome they cause (Figure 1.3).  
 
AOI, AOIII, LS and BD are all a result of gain of function autosomal dominant mutations and 
therefore this can be an indication of a new or increased action of filamin B such as an 
increased actin-binding affinity (Sawyer et al., 2009). Of the three main domains of filamin, 
the N-terminal actin binding domain (ABD) possesses several variants leading to AOI, AOIII BD 
and some LS cases (Robertson & Daniel, 2012).  
 
Within the two calponin homology (CH) domains of the actin binding domain (ABD), the 
causative missense mutations are primarily located in the CH2 domain. These can result in 
BD, while AOI, AOIII can also result from CH2 missense variants and occasionally variants in 
repeats 14-15 (Bicknell et al., 2005; Daniel et al., 2012; Farrington-Rock et al., 2006). Larsen 
syndrome can also be caused by missense mutations in the actin-binding domain as well as 
filamin repeats 13-17 (Bicknell et al., 2007; Sawyer et al., 2009) 
 
The CH1 and CH2 domains are both important for the actin-binding function of filamin B 
(Iwamoto et al., 2018; Sawyer et al., 2009). However, it was noted by (Sawyer et al., 2009) 
that while the CH1 is able to bind actin, the CH2 domain provides support by blocking actin 
binding on CH1. Furthermore it was also demonstrated that gain of function mutations in the 
CH2 domain causing AOI and AOIII, increased the actin-binding affinity of filamin B (Daniel et 
al., 2012; Sawyer et al., 2009). 
 
SCTS variants are distributed differently to those that cause the gain of function syndromes 
because it is a recessive disorder and variants in FLNB that produce loss of function alleles can 




While some Larsen syndrome cases result from a gain of function mutations in the CH2 
domain, most other cases result from variants in repeats 13-17 (Exon 25-33) surround hinge-
1 (Bicknell et al., 2007). While mutations in the CH2 domain have an ascribed mechanism to 
explain their causative effects (Sawyer et al., 2009), the mutations in other domains do not. 
Daniel et al., 2012 suggested that the mutations surrounding the hinge-1 of filamin B also 
increase the binding affinity of FLNB to actin producing a Larsen phenotype, but the 
mechanism behind such a gain of function remains unknown. This is a plausible hypothesis as 
the CH2 variants produce a protein with a stronger actin-binding affinity so the same 
mechanism could be produced by the variants surrounding the hinge-1 in order to produce 




Figure 1.3: Plotted Filamin variants against gene ontology 
Pathological variants plotted on FLNB. Exons are indicated in blue with the filamin B hinge-1 
highlighted in green as it is coded by a single exon. The layout shows areas of importance in 
relation to exons and syndromes. The syndromes are aligned with their cDNA pathological 
variant. Dt refers to the syndromes that were recorded as a dominat type, del as caused by a 
deletion and FLNB DS denotes and the clinician recording the individual as aflivted by a filamin 




1.3 Filamin family of proteins 
The name filamin originates from both the location of the protein and its abundance as a 
fibrillar cytoplasmic protein (Wang et al., 1975). The key function of the filamin proteins is to 
cross-link actin networks into orthogonal structures or stress fibres (van der Flier & 
Sonnenberg, 2001). The filamins are large cytoskeletal proteins consisting of two 280kDa 
subunits that make up a 160 nm dimeric structure. Filamins bind actin via an actin-binding 
domain (ABD) found at the N-terminal domain of the filamin protein. This functions to 
stabilise the actin filament lattice and links the cytoskeleton to proteins within the cell 
membrane (A.-X. Zhou et al., 2010). The filamin proteins are also known to form the scaffold 
for various cytoplasmic signalling proteins and provide an anchor point for a range of 
transmembrane proteins to the actin cytoskeleton (Li et al., 2018; van der Flier & Sonnenberg, 
2001).  
 
The filamin family are made up of three proteins, Filamin A, B and C encoded by the genes 
FLNA, FLNB and FLNC respectively (Tsui et al., 2016). These share approximately 70% 
homology with each other (A.-X. Zhou et al., 2010) however there is more variation seen in 
the hinge regions of these proteins where only 45% homology is observed. FLNA is X linked 
and consequently conditions caused by variants in this gene follow an X-linked pattern of 
inheritance. FLNA is also subjected to X-inactivation in females (Sheen et al., 2002). While 
FLNA is widely expressed, FLNC expression is restricted compared to the other two filamins 
and is mostly found in cardiac and skeletal muscles (Razinia et al., 2012; Sheen et al., 2002).  
 
Filamin A has been more extensively studied compared to filamin B and therefore there is a 
greater understanding of its function and interactions with other proteins. With this extensive 
knowledge and the homology shared between the two, filamin A can be used to guide  
understanding on how filamin B functions to cause FLNB related syndromes. In particular, 
when considering the role of filamin B in cell signalling and organ development in relation to 
developmental disease (Hu, Lu, Lian, Zhang, et al., 2014; A.-X. Zhou et al., 2010). 
 
When determining what functional defect is caused by the pathogenic variants found in FLNB, 
the high homology between filamin A and filamin B (Sheen et al., 2002) can be used to shed 
light as to why mutations in these particular regions may result in these syndromes and point 
to a possible cause as to why the corresponding phenotypes are seen.  
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1.3.1 The Filamin domains and functions 
Filamin B consists of an N-terminal actin-binding domain (ABD), a rod-domain in the center, 
containing hinge-1 and a C-terminal domain separated from the rod domain by a second hinge 
(Hinge-2) that forms tail to tail non-covalently associated dimers (Figure 1.4) (van der Flier & 
Sonnenberg, 2001). Studies of human filamin suggest that in the presence of hinge-1 this 
molecule forms a Y shape, where the F-actin binding domains forming the tips of the Y and 
hinge-1 the flexible bend (Takafuta et al., 1998). This molecular structure is the basis of its 
ability to build and order cytoskeletal structures and scaffold proteins (Heikkinen et al., 2009).  
 
The ABD is made of two calponin homology (CH) domains CH1 and CH2 and like other similar 
F-actin binding proteins, the two CH domains are separated by a linker (Sawyer & Sutherland-
Smith, 2012). The main function of a filamin dimer cross linking actin (Takafuta et al., 1998) 
via the F-actin-binding domain (ABD) at the N-terminal domain (Heikkinen et al., 2009). The 
filamins are the strongest F-actin cross-linking proteins (Clark et al., 2009; Nakamura et al., 
2007). Filamins are able to crosslink and stabilise F-actin networks and in doing so link these 
networks to cellular membranes, ultimately contributing to the linking network between the 
extracellular matrix (ECM) and the cytoskeleton of a cell (Razinia et al., 2012). Adjacent to the 
ABD is a central rod segment that is made up of 24 homologous repeats of approximately 96-
amino-acid residues, referred to as repeats, resembling immunoglobulin-like folds. The 24 
repeats that make up the bulk of the filamentous protein provide additional binding affinity 
for F-actin and they work to provide intrinsic flexibility to the actin lattice.  The flexibility of 
repeats 1 to 8 allow for the additional F-actin-binding domain (repeats 9–15) to achieve the 
best alignment for actin monomers facilitating F-actin binding downstream from the initial 
binding sites (Razinia et al., 2012; Sawyer et al., 2009; van der Flier & Sonnenberg, 2001; A.-
X. Zhou et al., 2010).  
 
The long rod domain is broken up by two hinge domains, Hinge-1 in between repeats 15 and 
16 and Hinge-2 (H2) and between repeats 23 and 24. Hinge 1 separates the 24 repeats into 
two rod domains and Hinge-2 separates rod-2 from the C-terminal (C-T) dimerisation domain. 
The filamin monomer protein is then able to form a dimer via the C-T dimerisation domain 




Figure 1.4: Filamin protein structure 
Representation of human filamin. The N-terminal actin-binding domain containing two 
calponin-homology domains (CH1 and CH2) is followed by 24 immunoglobulin-like repeats of 
∼96 amino acids each. The repeats are interrupted by two hinge regions (Hinge-1 and Hinge-
2) and fold into antiparallel β-sheets. The C-terminal twenty-fourth repeat is the dimerisation 
domain. Repeats 1–15 make up rod domain 1 and repeats 16–24 make up rod domain 2. 
Domain pairs 16–17, 18–19 and 20–21 are boxed in grey. Taken from Razinia et al., 2012. 
 
Filamin dimers increase the ability to actively build and maintain the actin networks by 
allowing for crosslinking of the F-actin at T, X or L shaped junctions. Each filamin monomer 
can bind to one actin filament, this dimerisation function serves to increase its overall 
effectiveness. (Baudier et al., 2018; Van Der Flier et al., 2002; Lu et al., 2007; Sheen et al., 
2002; Xie et al., 1998; A.-X. Zhou et al., 2010).The dimerisation of filamin also supports its 
ability to not only bind f-actin but regulate pathways in receptor activation and signal 
transduction within the actin cytoskeleton (Feng & Walsh, 2004).  
 
1.4 Role of filamin B  
The filamin B protein is coded by a 47 exon gene, FLNB, located at 3p14.3. This study done by 
(Razinia et al., 2012) indicates that filamin B is widely expressed during development. As 
indicated by this, filamin B plays important roles regulating the cytoskeletal structure and cell 
signalling (Baudier et al., 2018; Calderwood et al., 2001; Chen et al., 2012; D’Addario et al., 
2001; Daniel et al., 2012b; Van Der Flier et al., 2002; Gorlin et al., 1990; Hu, Lu, Lian, Zhang, 
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et al., 2014; Hu, Lu, Lian, Ferland, et al., 2014; Huelsmann et al., 2016; Ithychanda et al., 2009; 
Krakow et al., 2004). The filamin proteins integrate mechanical stress, cell signalling and 
transcription in organ development. With this in mind and considering the wide range of 
filamin B expression during development, we can begin to appreciate the complex range of 
symptoms and signs seen in syndromes associated with defective filamin B function. 
 
Filamin B is strongly expressed in chondrocytes. When these cells lack filamin they have a 
reduced ability to adhere to the ECM  (Razinia et al., 2012) and may indicate a possible role 
for filamin function within the knee joint during development.  
 
Mechano-regulation of the cell could be an integral function of filamin B just as it has been 
determined to be an important function mediated by its homolog filamin A (Sawyer et al., 
2009). Filamin is able to provide mechanical supportive protection due to its ABD and this 
allows a cell to survive physical forces within its environment. Filamin is able to provide this 
as it increases cellular resistance to external forces by crosslinking actin filaments of the actin 
network (Kainulainen et al., 2002; Sawyer et al., 2009).  
 
It was found by Kainulainen et al., 2002 that cells are able to detect external force and 
increase filamin expression to compensate for these forces, raising the cell’s durability and 
mechanical resistance and increasing cell survival rates. Although this study was conducted 
on filamin A, the similarities between FLNA and FLNB might indicate that a lack of filamin 
expression could reduce the cells ability to tolerate mechanical force, in cells that express 
filamin B more abundantly. In mouse embryonic fibroblasts (MEF’s) a lack of filamin B 
produces cells that have a decreased number of stress fibres, disorganised actin cytoskeleton, 
altered focal adhesions (Heuzé et al., 2008; W. Luo et al., 2013) and abnormal cellular 
spreading (Baldassarre et al., 2009).  
 
There is strong evidence demonstrating that filamin B can be observed in the cleavage furrow 
during cytokinesis as observed in chick embryo cells (Nunnally et al., 1980). In addition to this 
several studies have noted that other areas of the cell have lower amounts of filamin e.g. the 
periphery of the cell as the cell progresses through the cell cycle (Duff et al., 2011; Nunnally 
et al., 1980; Sheen et al., 2002a; Van Der Flier & Sonnenberg, 2001) 
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1.4.1 Filamin B hinge-1 
 There are two isoforms of filamin B which are the key focus of this project and provide an 
essential insight into the protein's function (Van Der Flier et al., 2002). Filamin B has a flexible 
hinge-1 coded by a single exon, exon 30 (Chakarova et al., 2000). This for reasons currently 
unknown can be alternatively spliced to exclude exon 30 to produce a hingeless filamin B 
transcript (NM_001164317.2 containing exon 30 and NM_001164318.2, with exon 30 
excluded). Two proteins, QKI and RBFOX1 have been identified via ChIP sequence analysis in 
breast cancer cells to be involved in the regulation of FLNB alternate splicing. In addition, the 
skipping of FLNB exon 30 induced epithelial-to-mesenchymal transition (EMT) by releasing 
the binding of FOXC1 transcription factor to FLNB. The phenomenon of native hinge-1 
exclusion splicing is of particular interest in Larsen syndrome as pathological variants are 
located around the hinge, potentially altering splicing recognition and hinge-1 exclusion (Li et 
al., 2018). 
 
The flexibility of hinge-1 is proposed to be critical for some filamin-actin interactions. Gardel 
et al., 2006 found that the hinge of filamin A and filamin B was essential in some of the strain 
resistant behaviour of cross-linked F actin networks. It was found that when placed under 
external mechanical strain an F-actin network could better resist the external stresses via use 
of the hinged filamins. This suggested that the hinged filamin A and filamin B were more 
effective in crosslinking f-actin in response to external stress (Gardel et al., 2006). 
Hinge-less filamin B is able to form a stronger bond to different integrin beta subunits than 
its hinged counterpart (Van Der Flier et al., 2002). Furthermore, the filamin B hinge is required 
to be excluded for the localisation of filamin B at the tips of actin stress fibres (Van Der Flier 
et al., 2002). These observations are evidence that a hinge and hinge-less filamin B is essential 
for organisation of the actin cytoskeleton and binding to transmembrane receptors such as 
integrins that help mediate extracellular matrix adhesion.  
 
1.4.2 Defining a role for FLNB in development 
Developmental expression patterns of FLNB are currently not well understood, particularly at 
a microscopic level in regions surrounding joint formation. Filamin B must have a critical role 
in the development of the large joints because of the dislocation phenotype seen in Larsen 
syndrome. Defining the structures and cells involved in these processes will inform us as to 
the role of filamin B in both developing and adult joints to shed light on its relation to the 
 19 
pathologies observed in diseases caused by gain of function. This will lead to the 
understanding of the physiological consequence of pathogenic variants in filamin B. Knowing 
what cell structures are in ligaments and tendons is essential knowledge for understanding 
the maintenance of joint integrity. If we can understand how this is done in both building and 
maintaining joints then we can begin to use this knowledge in regenerative medicine. 
Of particular interest is the role of hinge-1 during joint development and it is clear that Larsen 
syndrome causative variants are located in the domains surrounding hinge-1. Hinge-1 can be 
excluded from filamin B which will affect how cells sense and respond to mechanical stress., 
A custom mouse model was developed with eGFP inserted into hinge-1 in order to 
understand the role of hinge-1 in joint development. This enabled us to visualise which tissues 
are expressing FLNB hinge-1 using fluorescence.  
This model requires a large protein to be inserted into the middle of the filamin B protein and 
it is conceivable that this may interfere with the filamin B function especially relating to the 
hinge mechanism. However, Planagumà et al., 2012 demonstrated that when eGFP was 
inserted into hinge-1 of filamin A, little impairment was seen. It was demonstrated that in 
cells that were deficient in wildtype filamin-A, eGFP-Filamin-A was able to restore normal 
FLNA function. The placement was chosen to be in hinge-1 because the other regions were 
thought to be critical for filamin A function and hinge-1 placement was the least burdensome 
to the protein. When recombinant filamin A was expressed, that lacked the hinge-1, actin 
networks were still able to form in cells lacking filamin A however these were shown not to 
tolerate stress well (Planagumà et al., 2012). While it is important to note that the filamin A 
hinge-1 is important for proper stretching in the actin network and may be slightly hindered 
by the eGFP, we expected our mouse model to survive based on the work by Planaguma et 
al. 2012 and because there is a healthy copy of hinge-1 present. We also know the hinge is 
already occasionally excluded in osteoblasts (Tsui et al., 2016), however this study focous on 
the development of soft tissues and the stability they provide.  
This eGFP filamin B mouse model is not only able to indicate the location of hinge-1 inclusion 
or exclusion but is also a model that allows for conditional removal of exon 30 which encodes 
hinge-1. Using the cre-recombinase system the hinge-1 can be perinatally excluded from the 
protein across all tissues at all points of development. This may provide some understanding 
of the function of hinge-1, such as the nature of its role during development of the ligaments 
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or the integrity of these tissues once formed. As a result of this, the appearance of these 
structures will indicate how the hinge-1 excluded filamin B relates to known phenotypes and 
may elucidate the mechanism of these gain of function variants and how they may increase 




The ability for filamin B to intermittently skip hinge-1, encoded by a single exon, in various 
contexts might imply that this activity is connected to the pathogenesis of Larsen syndrome. 
This is because mutations that lead to this condition cluster around this alternatively spliced 
exon. Since joint dislocation is such an important feature of this condition and since the 
structure of the bones around these joint dislocations is relatively unimpaired, it is possible 
the alternative splicing of FLNB may be important in the formation and maturation of the 
stabilising soft tissue structures in these developing joints. Information surrounding the role 
of filamin B in development is sparse however, through this study, a better understanding of 
how some variants in filamin B may impact joint development by examining the soft tissues 
of mice at key developmental time points within the knee may emerge. 
For this project two transgenic mouse models will be used. Mouse model 1 utilises a red 
fluorescent label (mCherry), attached at the N-terminal end of the filamin B protein (Figure 
1.5). This mCherry tag was knocked into the endogenous Flnb locus of this mouse model. The 
utilisation of fluorescence microscopy will facilitate the localisation of filamin B with particular 
focus on those tissues that surround the knee joint. As this mCherry tag is attached by a 
flexible 9-residue poly-glycine linker to the N-terminus of Flnb it will give a readout of both 
hinge inclusive and exclusive isoforms produced from that allele.  
Mouse model 2 has filamin B tagged with a green fluorescent protein, eGFP. This tag is located 
within hinge-1 of filamin B. In addition, the model also has a Lox-P sites located either side of 
the filamin B hinge encoding exon, allowing hinge-1 to be removed via a cre-mediated 
recombination. On hinge-1 deletion either by the native splicing machinery or by cre/lox 
recombination, the eGFP tag will also be deleted making this isoform invisible in the 
fluorescent spectrum. As this tag is only within hinge-1 it will only be present when hinged 





Figure 1.5: Modified Alleles for Flnb studied in this thesis. 
Diagrams illustrating the two transgenic mouse models of filamin B. Model 1 is labeled with red 
fluorescent tag (mCherry, 568 nm) and model 2 has a green tag (eGFP, 488 nm). Model 2 has a 
recombinase mechanism to allow for the exclusion of the filamin hinge-1 (and subsequent tag). 
 
Heterozygotes mice lines carrying either the mCherry or eGFP tagged FLNB will be crossed to 
produce offspring with both mCherry and eGFP FLNB variants. Tissue from these mice will be 
imaged to detect whether filamin B hinge-1 inclusive or exclusive is present or not. This will 
allow for the localisation of the two forms in the cell in any tissue that Flnb is usually expressed 
in. Tissues or cells will appear red where only hinge-1-less filamin B protein (exon 30 excluded) 
is expressed. Alternatively, in tissues or cells where both hinged and hinge-less forms are 
expressed, these fluorescent tags should manifest as a merged (yellow) signal. This is 
assuming that both alleles are expressed equally and that the tags are not affecting the 






1. Mice expressing fluorescently tagged filamin B proteins will show patterns of hinge-1 
and hinge-1-excluded protein expression within soft tissues surrounding large synovial 
joints across different developmental time points.  
Microscopy data will be supported by quantification of transcriptional expression of 
filamin B hinge and hinge-less mRNA. 
 
2. The level of expression of filamin B hinge-1 and hinge-1-excluded transcripts in the 
soft tissues surrounding the knee of healthy mice will change across different 
developmental time points as shown by transcript quantification and microscopy. 
 
3. Filamin B hinge-1 knockout mice will show abnormal periarticular ligamentous 
structures surrounding the knee joint and produce a similar phenotype to Larsen 
syndrome. 
 
These hypothesises will be tested using the following aims: 
 
1 To examine the expression of hinged and hinge-less, fluorescently tagged, filamin B 
protein in the developing ligaments of the knee in healthy prenatal mice. 
 
 
2 To examine the protein expression of hinged and hinge-less, fluorescently tagged, 
filamin B protein in the developing menisci of the knee in healthy prenatal mice. 
 
 
3 To examine the protein expression of hinged and hinge-less, fluorescently tagged, 
filamin B protein in the post-natal ligaments and menisci of mice pups and compare post-
natal expression to pre-natal time points.  
 
 
4 To quantify FLNB transcripts across the time points using absolute quantification 
(qPCR) to understand the expression of filamin B hinge-1 in the developing knee joint.  
 
 
5 Examine the phenotype of a filamin B hinge-less mice to show how the loss of the 
filamin B hinge-1 may alter the structural integrity of the surrounding tissues of the joint 





2 Methods  
 
To examine hinge-1, the expression of hinged and hinge-less filamin B protein presence in the 
soft tissues surrounding the knee of healthy mice will be examined across 6 different time 
points of development using the fluorescent tags. These points range from embryonic time 
point 14.5 (14.5 days of gestation, E14.5) to postnatal time point day 4 (P4). 
A vaginal swab was taken at the beginning of each day using a steel loop to collect cells and 
smeared on a glass slide, these were then stained for 2-3 mins with toluidine blue. The cells 
can then be examined for pre-estrus and estrus by examining the cell shape a light 
microscope. These were the ideal times for pregnancy, but as metestrus closely resembles 
pre-estrus, estrus was used instead. Figure 2.1 below from Byers et al., 2012 was used to 
compare with experimental mice.  
 
Figure 2.1: Mouse menstrual cycle example(Byers et al., 2012) 
Three cell types are identified: leukocytes (circle), cornified epithelial (black arrow), and 
nucleated epithelial (white arrow). Stages of estrous include proestrus (A), estrus (B), 
metestrus (C), diestrus (D). (Byers et al., 2012) 
 
 
When a mouse was positive for estrus a timed mating could be set. This would be done by 
placing a male in the female’s enclosure at the end of the day (4-5pm) and then removing him 
in the morning (~9am). If successful mating overnight has occurred the embryos at this point 
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were assumed to be E 0.5 and no older. At 10 days of pregnancy the mouse will begin to gain 
~1.0 gram per day, this was an excellent indicator of an established pregnancy however, 
palpation for pups can also confirm pregnancy at 10 days or more.  
 
 
2.1 Dissections and tissue harvesting 
For postnatal time points, the mouse enclosure was placed on-top a heating pad with mother 
and pups inside. Each pup was collected individually and culled via decapitation. The left and 
right lower limbs were collected without any force applied to the knee joint. From this point 
all handling of tissues was done limiting exposure to light. The knee joint had 3-6 holes made 
with a 12 gauge needle to allow for optimum fixing. The tissues were then labelled in a tube 
with a 4% Paraformaldehyde (PFA) and PBS fixative, wrapped in tin foil to shield from light 
and left at room temperature for 4 hours. In a separate tube a tail tip was collected for 




Figure 2.2: Mouse dissection diagram	
Mouse A, shows the incision lines for removing the uterus. Mouse B line of transection for 
the lower limbs that were collected. Adapted from (Evolving Sciences, 2019) 
 
For embryonic time points, the dams were culled via cervical dislocation and death was 
confirmed by a toe pinch on all four limbs. The mother was sprayed with 70% ethanol, two 
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incisions were made laterally one just above the where lower limbs attached the second just 
below the ribcage. A third was made down the midline to join them. The uterus was 
visualised, removed and placed in a petri dish with sterile PBS and covered with tinfoil. All  
handling of tissues had limited exposure to light. Each pup was collected, decapitated and a 
tail tip was collected for genotyping. This was the same label as the lower limbs from the same 
pup and was stored at 4°C.  
The lower limbs were then collected without any force applied to the knee joint. The limbs 
were collected as per Figure 2.2, allowing for a margin of error as the knees were not easily 
visible on very young pups. E18.5 and older embryos had 3-6 holes poked in the knee joint 
with a 24 gauge needle to allow for optimum perforation of the fixing agent. The tissues were 
then labelled in a tube with a 4% PFA and PBS fixative, wrapped in tinfoil and left at room 
temperature for four hours.  
 
2.1.1 Tail tip digest 
The mice were genotyped to sex the pups and to determine which tissues needed to be cryo-
cut and mounted. The tail tips were each digested in 100μl of 25mg/mL of Protease K in a 
digestion mix buffer (appendix) at 55°C for 3-4 hours, cooled on ice for 1 min before adding 
40μl of tail-tip-salts to each sample (appendix). These were vortexed and then spun at 
15,000rcf for 10 minutes. For each sample, 45μl of absolute ethanol was added to 20μl of 
post spin supernatant. The samples (65μl) were lightly mixed and then spun at 15,000rfc for 
5 minutes. The supernatant was removed and 100μl of 70% ethanol was added. The samples 
were mixed well and then spun again at 15,000rcf for 3 minutes. The supernatant was 
removed and the tube left to air dry, ~5min. Once dry the pellet was resuspended in 200μl of 
auto-claved Milli-Q H2O and left to rehydrate overnight.  
 
2.1.2 Limb processing and freezing 
After fixing (and in a low light working environment) the tissues were dehydrated in sucrose. 
The tissue was placed in 15% sucrose for at least 24 hours in the dark, followed by 30% sucrose 
dehydration for 2-4 hours until fully dehydrated as indicated by the tissues sinking to the 




Figure 2.3: Knee planes 
Figure 2.3 is of a P5 mouse pup knee joint  orientated in the sagittal plane with the femur 
labled as A, tubula as B and the knee joint space as C.  
 
The mouse tissues were set in OTC (Scigen Tissue-Plus, 4583) in an orientation that allows for 
cutting along the sagittal plane of the knee joint as shown in Figure 2.3. This provided a good 
orientation for observing the ligaments and key land marks such as the femur, tibia and 
patella. Once fully covered in O.T.C the mould holding the tissue was frozen by placing it on 
the surface of isopentane that has been cooled via liquid nitrogen. The frozen tissue was then 
wrapped in tinfoil, limiting the amount light exposer and labeled. All tissue was stored at -20 
overnight or at -80 for long-term storage.  
 
All tissues were cut in minimal light at -19 to -20 digressed at 8 microns thick for the inverted 
microscope, then cryo-sections were mounted 2-3 a slide with Prolong Gold with DAPI 
(Thermofisher Scientific) and cured for 2-3 hours at room temperature. For the confocal 
microscope, the sections were cut to 30 microns sections. These cryo-sections were mounted 
1 per slide Prolong Gold and cured for 2-3 hours at room temperature before imaging. 
 
2.2 Genotyping PCR 
There were two sets of genotyping primers and one set of sex determining primers. The 
primers for detecting the fluorophores flanked the modified region, therefore producing two 









Table 2.1: Mouse genotyping primers 
eGFP Forward ATGGGGAAGTCACAGCCATG 
eGFP Reverse CCTTTCCTGACGGCAAATGG 
MCherry Forward GTCATGGTTACAGAAGAGGCCT 
MCherry Reverse GCGTATCTCACAGTGACCGT 
Sex Forward GAGGCTACCCAACAACCACA 
Sex reverse CTGTCAGAAGGCCGGACTTT 
 
 
A master mix for eGFP, mCherry and sex determination was made for easier distribution 
of the various reagents. The following shows the required reagents per sample.  
 













1.0µl 1.0µl 0.6µl 0.1µl 0.8µl 0.8µl 0.05µl 5.85µl 
 
 
PCR reagents used were as follows: 10X PCR Gold Buffer Applied Biosystems. MgCl2 Applied 
Biosystems (25mM). Taq Polymerase was AmpliTaq Gold 5 U/µl (Applied Biosystems) 
4486227 lot:00710444.  1μl of the extracted tail tip DNA was used in each reaction.  
Table 2.3 summarizes the PCR reaction protocol. 
 
Table 2.3: Thermocycler PCR steps for genotyping 
Step Temperature ℃ Time Repeat 
Initial denaturing 94 10 minutes  
Denaturing 94 30 seconds Repeat for 34 
cycles Annealing 55 30 seconds 
Extension 72 2 minute 
Final extension 72 10 minute  
Cooling 4 Forever  
 
Gel electrophoresis was used to visualise amplified DNA with a 100bp ladder for size 
determination. All gels used were run on a 2% agarose gel I0.5x TBE buffer. PCR products were 
visualised with SYBR Green Loading Dye. PCR products of 500> bp were run at 200 volts for 
10-20 minutes. Gels were imaged on UVITEC Cambridge gel dock. 
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2.3 Tissue Histology   
2.3.1 Hematoxylin and Eosin (H&E) 
Hematoxylin and eosin (H&E) stain's the nuclei blue to blue-black and connective tissues 
fibres red to pink. Slides were rinsed with dH2O to remove OCT. They were then stained in 
Gill’s ll hematoxylin for 4 minutes, then washed in running tap water for 2 minutes. They were 
then placed in Scott's tap water for 2 minutes before being washed in running tap water for 
2 minutes. They were then stained in eosin for 30 seconds and washed in running tap water 
for 1 minute before being dehydrated with xylene and left to sit on the bench top to dry 
before being cover-slipped. Nuclei appear purple/blue. Eosinophilic granules stain bright pink. 
Cytoplasm and other tissue elements appear in various shades of pink.   
 
2.3.2 Tri-stain  
The tri-stain stains the cartilage within the tissues an orange to red colour, the muscle tissue 
pink and the collagen fibers blue. Slides were washed in dH2O to remove the OCT and then 
placed in safranin-O for 5 minutes and then washed again in dH2O. The slides were then 
placed 0.5% acid fuchsin for 3 minutes, washed again in dH2O and placed in 1% 
phosphomolybdic acid for 1 minute before being blot-dried with filter paper. The slide was 
then placed in 2% Methyl Blue for 10 minutes and then transferred straight to 1% Acetic Acid 
1 minute with constant agitation. The slide was then rinsed in dH2O and dehydrated in 100% 
ethanol before being xylene cleared and mounted.  
 
2.4 Imaging protocol 
For consistent imaging all images were taken using microscope using the same settings, unless 
otherwise specified. 
 
2.4.1 Olympus BX54 inverted microscope 
Slides were imaged on an Olympus BX54 microscope equipped with an Olympus DP80 camera 
using the Olympus CellSens software (v.1.6). The exposures used were 250ms-900ms, at an 
ISO sensitivity value of 200-400 depending on the channel and time point, these were 
specified for each image. Imaged sections were cut to 8 microns.  
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2.4.2 Nikon A1 Inverted Confocal microscope 
The laser intensity was constant at 20 mW. Sections were cut to 30 microns to allow for clear 
images while still allowing for a Z-stack series. To ensure the best quality image with minimal 
fluorescence fading, Prolong Gold with DAPI (Thermofisher Scientific) was used as a mounting 
agent for 8-micron thick sections. Prolong gold without DAPI (Thermofisher Scientific) was 
used as a mounting agent for 30-micron sections as the DAPI produced interreference with 
confocal imaging. Initially DPX was used, however for fluorescence, DPX was causing the 
tissues samples to become auto-fluorescent. 
 
For each time point there were a standard set of images taken. 
- 1x bright field overview of the whole knee at 4x. 
- 1x Bright field and florescence of visible ligaments and meniscus at 10x. 
- 1x Middle section of the joint and both sides, showing ligament attachment points and 
the edges of the meniscus (3 total) both florescence channels and a bright field image. 
The fluorescent images were acquired following excitation at three different wavelengths for 
the detection of total filamin B. Detection of the filamin protein with the mCherry tag was at 
a wavelength of 568 nm. The hinged filamin B, eGFP which was directly associated with the 
hinge, was detected at a wavelength of 488 nm. Detection of DAPI, which was added when 
the tissues were fixed in Prolong Gold, was at 340 nm. The use of DAPI as a nuclear marker 
allow for the fluorescent visualization of regions of the tissue that were cellular but may not 
have filamin B expression. 
 
The images were acquired in the order of Green (488 nm) channel, Red (568 nm) channel, 
Blue channel (358 nm) and bright field. When imaging with 2 or more wave lengths, the 
exposure and gain was kept constant with the exception of DAPI. Black balance was used and 
calibrated to the least bright channel (green, 488 nm) to reduce over exposure and to better 
define fluorescent regions. Exposure of tissue to natural light was reduced at all possible 
points of tissue processing with tinfoil. Imaging was done primarily at 20x magnification as 
this best shows the ligamentous structures and meniscus as well as a clear fluorescence image 
across all time points. 
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2.5 HiFi ligation  
Two plasmids constructs were made to optimize Flnb isoform-specific primers. This was done 
in 2 steps, production of a Exon 30 (hinge-1) excluded filamin B cDNA fragment and 
production and purification of a plasmid each with an individual hinge-1 inclusive or exclusive 
fragment. 
 
Table 2.4: Plasmid primers 
15 Forward TACAAGGATGACGATGACAAGTAAGACCGGACGCTATATGATTGG 
20 Reverse  CGATATCAGATCTATCGATGGCTGCCCCTGTACTTGATGT   
Ex29:31 Forward CCCTTCACAGTCATGGTTACAGAAGAGGCC 
Ex29:31 Reverse GGCCTCTTCTGTAACCATGACTGTGAAGGG 
 
Two sets of primers were used to amplify a section upstream (R15) and a section downstream 
(R20) of exon 30 (hinge-1), with the middle two primers over lapping, refer to Figure 2.4 
below.  
 
Filamin B Hinge-1 exclusion primer diagram 
 
Figure 2.4: Hinge-1 exclusion primer diagram 
Figure 2.4 shows the primer annealing sites that allowing for hinge-1 excluded products 
within the filamin B cDNA 
 
Using a filamin B cDNA template, two PCR products were amplified using the reagents as per 
Table 2.2, the thermocycler steps were as per Table 3.3, however the annealing temperature 
was 60℃ and the cycle count was only 20 repeats.  The DNA polymerase used was a mix of 
60% Roche PWO DNA polymerase 19212820 and 40% Taq Polymerase was AmpliTaq Gold 5 
U/µl (Applied Biosystems) 4486227 lot:00710444. Using the intensity indicated by photoshop 




pmols = (ng x 1000)/(bp*650) 
 
This was calculated to be 80.066 for R15 and 91.511 for R20. Each product was diluted to a 
concentration of 60ng/μl for the ligation reaction.   
 
Table 2.5: Ligation reaction mix 
P3xFlag plasmid Vector  1μl at 20ng/μl 
R20 PCR Product 1μl 60ng/μl 
R15 PCR Product 1μl 60ng/μl 
HiFi Master mix 5μl 
dH2O Up to 10μl (2μl) 
 
The mix was then ligated as per the protocol outlined in NEBuilder® HiFi DNA Assembly 
Master Mix/NEBuilder HiFi DNA Assembly Cloning Kit manual. The plasmid was then 
assembled as per the protocol provided by biolabs NEBuilder® HiFi DNA Assembly Master 
Mix/NEBuilder HiFi DNA Assembly Cloning Kit Instruction Manual.   
 
2.6 Transformation 
Competent bacteria (E. coli) were placed on ice until thawed. 8µl of the ligated plasmid was 
added to the cells and left on ice for 1 hour. After 1 hour the cells were heat shocked at 42℃ 
for ~40 seconds and then placed in ice for 2 mins. 400µl of LB broth with no antibiotic, was 
added to the cells and incubated at 37℃ for 1 hour.  The cells were then spread dry agar 
plates with carbenicillin and leftover night to allow colony growth. 
 
2.7 Plasmid preparations 
Plasmid extraction was performed using the NucleoSpin Plasmid miniprep kit, Lot 1809/006. 
The extraction was performed as per the protocol dictated by the NucleoSpin Plasmid 
miniprep kit. 2μl of each miniprep sample was measured on the ThermoScientific NanoDrop 
1000 spectrophotometer using NanoDrop 1000 3.8.1 software, with the MilliQ H2O used to 




2.8 Sequencing and plasmid clean up 
The ligated plasmid products were divided into “forward” and “reverse” samples for each 
gene sequening from the 5’ for forward and the 3’ for the reverse. 1μl of the buffer, 2μl of big 
dye and 1μl of Forward OR reverse primer. The BigDye (Applied Biosystems) reaction was run 
on the Bio-Rad thermocycler as per the steps listed in Table 2.6 
 
Table 2.6: Thermocycler sequence clean up steps for BigDye 
Step Temperature ℃ Time Repeat 
Initial denaturing 96 1:15 minutes   
Denaturing 96 45 seconds Repeat cycles 24 
times Annealing 50 45 seconds 
Extension 60 3:30 minutes 
Cooling 4 Forever  
 
Once complete, the samples were dried by adding 62μl of ethanol sodium acetate to each 
mix and incubated at room temperature for 30 min. Then the samples were spun at maximal 
speed in the centrifuge for 20 min and then the supernatant poured out. 70μl of 70% ethanol 
was then added and spun again at maximal speed for 10 min. The supernatant was poured 
off and left to dry ~30 minutes. Samples were capped and stored in fridge or freezer before 
sequencing by Otago Genetic Analysis (Department of Anatomy, University of Otago) using 
capillary sequence analysis. 
 
2.9  qPCR 
qPCR was used to quantify the amount transcript RNA in a sample. To understand the function 
of hinge-less vs hinged filamin B in the develop of the soft tissues of the knee joint, two sets 
of primers were designed to detect both types. A third set was designed up stream of the 
hinge to detect total filamin B. 
 
Table 2.7: Hinge quantification primers 
Hingeless Forward GGGGAAAGTAACCTGCGTGA 
Hingeless Reverse AGGCCTCTTCTGTAACCATGA 
hinged Forward GGGGAAAGTAACCTGCGTGA 
hinged Reverse CTGTGACTTCCCCATCGGTG 
Control Forward CCGAGAAGTGGGTGAGCATC 




When validating the primers all plasmid samples were diluted to 1ng/μl for quantification and 
done in duplicate. This was calculated using the initial concentrations read from the nanodrop 
and diluting a portion with Milli-Q water.  
 
Calculation as - C1 x V1 = C2 x V2 
 
Table 2.8: qPCR reagents 
Reagent Amount per sample  
LightCycler 480 SYBR Green master 
mix 1 (Roche) 
10 μl 
Forward primer 1μl 
Reverse Primer 1μl 
H20 3μl 
cDNA from patient or control  5 μl 
 
The reactions were made up as a master mix (Table 2.8) prior to the addition of plasmid to 
reduce error. Twelve sets of primers were initially used for the qPCR to test specificity, with 
an outcome of three sets being successful. Five different concentrations of plasmid used of 
either hinge or hinge-less filamin B were prepared by serial dilution. The concentrations used 
were: 1.0ng/μl, 0.1ng/μl, 0.01ng/μl, 0.001ng/μl, 0.0001ng/μl. Each sample was used in 
duplicate for each primer set. Milli-Q water was used in place of plasmid for the negative 
controls. The plate was sealed and centrifuged for 5 minutes at 2000rpm before being run in 
the LightCycler 480 II real-time PCR machine; steps are outlined in Table 2.9 
 
Table 2.9: Light cycler steps (qPCR) 
Step Temperature ℃ Time Repeat 
Initial denaturing 95 5 minutes  
Denaturing 95 10 seconds Repeat cycles 45 
times Annealing 60 10 seconds 
Extension 72 10 seconds 
Melting curves 72-95 Until complete  
 
At the end of each extension phase acquisition for quantitation, these absorbance curves 
were to determine the amount of product after each cycle. The LightCycler 480 software 
version 1.5.1.62 SP3 was used to produce melt curves to determine primer fidelity and off 
target amplification.  
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2.10 Mouse Embryonic Fibroblasts (MEF’s) 
2.10.1 MEF culturing 
All MEFs were grown in prewarmed  Dulbecco's Modified Eagle Medium (DMEM) growth 
media supplemented with 10% foetal calf serum (FCS) and 1% Penicillin/Streptomycin (P/S).  
All cells lines P6 and older were grown in 16ml of media in a medium (75cm3) flask at 37℃ at 
5% CO2. Small flasks had 4.5ml of media. All cells lines P5 and younger were grown in 16ml of 
media in a medium (75cm3) flask at 37℃ at 5% CO2 and 5% O2. Small flasks had 4.5ml of 
media. These were to mimic embryonic conditions as this was found to maintain fluorescent 
expression up until around P6 and P7. 
 
 
2.10.2 De-frosting and freezing MEFs 
The MEFs were lifted using 3ml of trypsin over 10-15 minutes.  3 ml of fresh media was added 
to deactivate the trypsin and the total 6ml was spun at 250 rpm for 5 minutes to form a pallet. 
This was then re-suspended in 4.5ml of  88% DMEM (Gibco) with 10% foetal calf serum (FCS), 
2% Penicillin/Streptomycin (P/S) and 500μl of DMSO. The 5ml's was aliquoted out into five 
1ml cryotubes and sealed with a screw lid. These were placed in a container insulated with 
isopentane to slow freezing and then placed in the -80 freezer. 1-2 days later they were taken 
out and placed in the appropriate container. 
To thaw the MEFs, they were placed in a 37°C water bath for 5 min and then transferred to 
10mls of media and spun down at 250rpm for 5 min. The supernatant was removed and 




2.11.1 Cell immune-staining from PFA fixing 
MEF cells were plated on a 24 well plate, with a sterile glass coverslip at the bottom for cells 
to grow on. Three protocols for fixing were trialled to preserve the endogenous cellular 
fluorescence:  
1. After media was removed the cells were fixed in 4% PFA in PBS for 5 minutes, then washed 
once in PBS for 3 min. After they were blocked and permeabilised in 5% FCS/0.2% Triton (FCS 
from Sigma, Triton Fisher Scientific) in PBS for 5 min.  
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2. After culture media was removed and an additional 5 minute wash in PBS, the cells were 
fixed in -20℃ methanol, before aspiration and subsequent washing in PBS. 500μl of -20℃ 
methanol was added to each well and the whole plate incubated at -20℃ for 5 min. The 
methanol was removed and cells washed once in PBS.  
3. After media was removed cells were fixed at room temperature in methanol. The media 
was lifted from the cells and the cells washed once in PBS. 500μl of room temperature 
methanol was added to each well and the whole plate incubated at room temperature for 5 
minutes. The methanol was removed and cells washed once in PBS.  
 
The primary antibody gamma tubulin was added at a dilution of 1:5000 in a 1% FCS in PBS 
mix. A minimum of 250μl was used to cover the bottom of well and glass disk in 24-well plate. 
This was incubated for 60 minutes at room temperature followed by two washes in PBS at 3 
minutes each. The secondary antibody was made to a 1:5000 dilution in 1% FCS in PBS and 
was incubated in the dark 20 minutes, 500μl was used to cover the bottom of each 24 well 
containing a coverslip. This was then washed once in PBS for 3 minutes. 
The second primary antibody to mCherry was added at a dilution of 1:1000 in a 1% FCS in PBS 
mix. A minimum of 250μl was used to cover the bottom of well and glass disk in 24-well plate. 
This was incubated for 60 minutes at room temperature in the dark followed by two washes 
in PBS at 3 minutes each. This was done separately as this was a conjugated antibody.  
Coverslips were carefully removed from the wells with forceps and mounted on slides using 
the mounting agent Prolong Gold, with or without DAPI and left at room temperature for 1-2 
hours to cure. The slides were subsequently imaged on an Olympus BX54 upright microscope 





3 Filamin B in the developing joint 
To understand the role of the hinge-1 region of filamin B in the stability of the joint in Larsen 
syndrome, expression of filamin B, specifically the hinge-1 inclusive and hinge-1 excluded 
forms of the protein, was investigated during joint development. In order to do this, the 
expression of the two forms, each labelled with a fluorescent marker, was studied using 
fluorescent microscopy across key developmental time points. The aim here was to 
determine at what stage, if any, the two forms of filamin B (hinge-1 inclusive or hinge-1 
exclusive) could be detected in the developing knee tissues and if detectable, whether or not 
they are present separately or co-localise and at what time point either form of the protein 
begins to appear, intensify and attenuate.  
The hypothesis that Larsen syndrome joint dislocations relate to dysfunction of the soft 
tissues around the knee joint could then be addressed with these data in hand. The detection 
of hinged and hinge-less, fluorescently tagged, filamin B protein will be examined for in the 
developing ligaments and menisci of the knee of pre-natal and postnatal mice. These 
observations will be related to the clinical characteristics noted in filamin B related 
syndromes. 
 
3.1 Mouse model constructs  
The two models, eGFP-LoxP filamin B and the mCherry filamin B mice were designed by 
Cyagen using their TurboKnockout® Gene Targeting system. The colonies were established at 
Otago University by the Clinical Genetics Group. These mice were bread at the Taieri animal 
facility under the AUP-17129 breeding protocol. The mice models were used in experiments 
at the HTRU animal facility under protocol 18-18. 
All animal manipulations were carried out under ethics protocol AUP 18-18 as approved by 
the institutional animal ethics committee (University of Otago). Two variations of tissue 
collections were utilised as embryonic times points require the mother to be culled in order 
to collect the embryos and postnatal time points do not 
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3.1.1 Mouse estrus screen and crosses 
All mice are crossed as a timed mating so the exact age of the embryos are known. All mice 
used are EITHER modified mCherry/filamin B heterozygotes OR modified eGFP (LoxP)/filamin 








Figure 3.1: Punnet square diagram showing the mated cross of mice used to generate pups 
for experimentation colour-coded to for filamin expression 
 
The punnet square diagram shows all the possible modified filamin genotypes produced from 
the crosses. The colours are indicative of fluorophore detection colour and therefore also 
indicate usefulness of each pup with that genotype, as only orange will indicate both isoforms 
of FLNB. The calculated ratio of pups for this cross was 1:1:1:1, this will produce a control 
negative (the wild type, WT) and individual fluorophores (eGFP OR mCherry) to allow for 
comparison to the eGFP and M-cheery hybrid for analysis. 
 
The observed ratio for the crosses produced was:  
 
MCherry-FLNB : eGFP-FLNB :  MCherry-FLNB & eGFP-FLNB : Wild Type 
2.5 : 1.6 : 2.6 : 1.6 
This was obviously not what the expected calculated ratio predicted however this only uses 
6 litters of pups and therefore the small sample size will result in a more influenced ratio. It 
should be noted that in future research if the hinge-1 is excluded, close attention to the 
genotype ratios will be needed to observe a possible lethality or reduced embryo-viability of 
a filamin B hinge-1 free mouse. These ratios suggests that that there is a selective pressure 
on the heterozygotes, however due to the small sample size this is inconclusive. In order to 
ensure all samples were were producing images that were the same three eGFP and M-cheery 














hybrids were sectioned imaged and check for replicability and the best images were used to 
represent that time point.  
 
3.1.2 Chondrocyte columns and filamin B expression and divisional plane 
 
 
Figure 3.2: Chondrocyte columns filamin B expression and divisional plane 
Figure 3.2: Chondrocyte columns of the femur of a P2 mouse (shown in a sagittal plane) lower 
right corner is the distol end of the femur. There is high filamin B expression in the bones. The 
pink circles show the chondrocyte columns, with cells stacked closely next to each other. The 
white circles indicate the eGFP only cells, a phenomenon observed throughout the study. A, 
filamin B with the hinge present, (eGFP, 488 nm). B, filamin B detection independent of the 
hinge, (mCherry, 568nm). C, eGFP and mCherry channels merged to show both filamin alleles 





Here the chondrocytes can be seen dividing (as indicated by a bright gold band which is the 
cleavage furrow, blue arrrow) along a single plane. This may provide insight on the relation 
to AOI and the short bones seen in this condition, as a disruption to cell division along the 
plane that produces the long bones may result in less proliferative cells and therefore a 
shorter bone.  
 
Through the project it was observed that a small number of cells within the mouse tissues 
were only detectable with eGFP as observed in Figure 3.2. This was hypothesised for red only 
cells; however the green cells were unexpected. It is not currently known why these are seen 
in the tissue but it does appear to be vaguely divisionally related as they appear in groups 
within the chondrocyte columns. This is most likely an artefact from the production of the 
mice strain. 
 
3.2 Expression of filamin B in developing joints 
Importantly, the expression of the two tagged filamin B proteins is detectable at different 
wavelengths in these experiments. eGFP is represented in the figures as green and detectable 
at a wavelength of 488nm. eGFP is located with the hinge-1 of filamin B and therefore any 
green signal seen in the images represents filamin B with hinge-1 included. mCherry is 
represented as red and is detectable at a wavelength of 568nm. This fluorophore is located 
as an N-terminal tag and therefore will show filamin independent of hinge-1. 
 
Initially, tissue from the mCherry/eGFP mouse hybrid knee joints from a postnatal day 2 (P2) 
mouse was examined. This showed that there were high levels of expression in the 
chondrocytes in the epiphyseal growth plates of the tibia and femur as the cells were clearly 
yellow indicating that both filamin alleles (red and green) were being expressed in these cells. 
This helps in the validation of the model, as the observation of filamin expression in the 
developing bones, the chondrocytes, is consistent with previous literature (Krakow et al., 
2004).  
 
Following this, other embryonic and postnatal time points were collected with attention given 
to imaging areas of significance, such as the peri and intra-articular ligaments and the menisci. 
These are deemed significant sites as the knee joint is a hinge joint that relies heavily on the 
ligaments for its stability and for the menisci to provide shock absorption and joint stability 
as well.  
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Total filamin B expression across five development time points with special focus on ligaments 
Figure 3.3: Levels of total filamin B expression increase and then decrease in Ligaments from 




















Figure 3.3: The knee joint across three embryonic time points A-C, (E14.5, E15.5, E16.5) and two 
postnatal points, D & E (P2, P4). The images are shown in sagittal sections of the knee joint between 
the distal point of the femur and the proximal point of the tibia. 
The joint is orientated with the femur in the top left corner of each time point and the tibia at the 
bottom right. Ligaments are indicated with blue arrows and representative chondrocytes cells are 
circled in pink. A grey “F” indicates the bottom of the femur and “T” indicates the top of the tibia.  
Filamin B with the hinge present is represented as green, (eGFP, 488 nm). Filamin B detection 
independent of the hinge is represented as red (mCherry, 568nm). Images A-E are eGFP and mCherry 
channels merged to show both filamin alleles (total filamin B). Co-expression of both forms of filamin 
B appears yellow. Panel F shows an overview of the knee joint (adapted from (LaPrade et al., 2015)). 
The white arrows indicte the band of red puncta. 
 
In Figure 3.3 (A-E) both hinged (green) and hinge-1 excluded (red) filamin B are present at 
E14.5, E15.5 E16.5 as well as both postnatal time points P2 and P4. Both alleles of filamin B 
are visible at all time points in the chondrocytes (shown enlarged in Figure 3.2 & 4.8). in the 
distal epiphyses of the femur and tibia. However, the overall fluorescence is less intense per 
cell at time point P4, as the bones become more mineralised (Miller et al., 2007).  
At the first two time points (E14.5 and E15.5), structures between the developing bones in 
the nascent joint space are poorly defined (Figures 3.3A, 3.3B) and neither ligament nor 
meniscus structures can be seen. However, there is detectable filamin B expression in this 
tissue. The top left panel (Figure 3.3A; E14.5) shows a number of red punctate structures 
(indicating hinge-1 excluded filamin) surrounding the cell membrane along the border of the 
femur, indicated by a white arrow within the region of the knee joint between the femur and 
tibia. The highest level of filamin expression at this stage in development is in the 
chondrocytes of the femur and tibia with lower expression seen in the joint space between 
them. 
 
At E15.5 (Figure 3.3B) there are more defined red punctate structures that appear in or just 
below the cell membrane of the cells, in the centre of the joint (indicating hinge-1 excluded 
filamin), surrounded by cells with lower filamin expression. Therefore, the majority of 
expression seen between the tibia and femur (within the joint space) is that of filamin without 
hinge-1. The femur and tibia show the highest level of expression for both filamin alleles 
within the chondrocytes (circled in pink) and are represented as yellow cells. The cells that 
are seen within this joint space may represent those that will ultimately form ligamentous 
structures that begin as a coalescence of cells indicated by the red puncta marked. However, 
it is unclear at this point if the red puncta found at this time point migrate to form that 
attachment point between the ligament and the ends of the bones or form the ligament itself 
or neither. 
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At E16.5 (Figure 3.3C), the knee joint appears to be more differentiated and with more 
identifiable structures. Within the joint space low, filamin expression is seen, however, it is 
still very cellular, as indicated by the DAPI staining (Figure 4.2). Filamin B with excluded hinge-
1, indicated by red puncta, is no longer evident within the joint space. Chondrocytes within 
the femur and tibia still show strong filamin B expression of both forms at this timepoint. The 
outlines of the developing ligaments can be seen here and are indicated with blue arrows. 
These are further examined later in the chapter. 
P2 (Figure 3.3D) shows a developed knee joint with defined structures. At this time point, the 
pups are weight-bearing and therefore the knee joint has been subjected to mechanical 
forces. Within the joint space, moderate levels of filamin B expression are seen, with both 
forms are present in the ligament, as indicated by the blue arrows. There are no red punctate 
structures (hinge-1 excluded filamin) visible in the joint space or ligaments as seen at earlier 
time points suggesting that these structures may have dispersed or that the cells containing 
them may have migrated. These cells may have migrated, possibly to the bone attachment 
points or that the function of this filamin B form is now obsolete and it dissipates as the cells 
differentiate. It is likely that the expression has been downregulated however this conclusion 
can not be made without the RNA quantification data. The growth plate chondrocytes still 
express a high amount of filamin B as indicated by yellow fluorescence and are seen in both 
the femur and tibia. 
The lower left panel (Figure 3.3E; P4) shows a terminally developed knee joint characterised 
by well-defined structures. This joint space, particularly the ligaments (blue arrows) show very 
low to nearly no filamin B expression. There is also a comparative reduction in filamin B to 
that seen at the earlier time points within the femoral and tibial growth plates (highlighted in 
the pink circle).  
 
Analysis of all the time points shows that expression of both hinge-1 inclusive and hinge-1 
excluded filamin is present across all time points, especially in the epiphyseal chondrocytes. 
This is indicative of high FLNB expression in the developing bones which is supported by the 
observations made previously (Krakow et al., 2004). While the critical points at which the 
ligaments develop are observed here, they are not expressing filamin B as strongly as seen in 
the epiphyseal chondrocytes. However, the interesting observation here is that there are 
significant aggregations of hinge-1 excluded filamin B protein present in the ligaments. This 
suggests there are cells that require no filamin B hinge-1 for the correct development of these 
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joint soft tissues. Furthermore, these hinge-1 excluded puncta are only located within the 
joint space and only seen during this narrow point of development at 15.5. There is also an 
overall reduction in filamin B expression in these structures over this time course. 
 
Together with ligaments, the other important soft tissue to consider in relation to joint 
stability is the meniscus. The expression of the two forms of filamin B in this tissue is also of 




Total filamin B expression across five development time points with special focus on the meniscus  
 
Figure 3.4: Levels of total filamin B expression increase and then subsequently decrease in 












Figure 3.4. The development of the knee joint across 3 embryonic time points (A-C; E14.5, E15.5, 
E16.5) and 2 postnatal points (D & E; P2, P4). Sagittal images of the knee joint including the distal 
femur and proximal tibia are shown. The joint is orientated with the femur in the top left corner and 
the tibia at the bottom right in each image. The meniscus is indicated with blue arrows and a few 
representative chondrocytes cells are circled in pink. A grey “F” indicates the bottom of the femur and 
“T” indicates the top of the tibia.  
Filamin B with the hinge present is represented as green, (eGFP, 488 nm). Filamin B detection 
independent of the hinge is represented as red (mCherry, 568nm). Images A-E are eGFP and mCherry 
channels merged to show both filamin alleles (total filamin B). Co-expression of both forms of filamin 
B appears yellow. Panel F shows an overview of the knee joint (adapted from (LaPrade et al., 2015)). 
 
Here the focus was on the presence of hinged filamin B (indicated by green) and hinge-1 
excluded filamin B (indicated by red, but also indicating total filamin, because this allele can 
still have the exon encoding the hinge spliced in or out) for embryonic time points E14.5, 
E15.5 E16.5 and postnatal time points P2 and P4 in the developing meniscus. As previously 
shown in Figure 3.3, both forms of filamin are present in the epiphyseal chondrocytes 
(indicated in the pink circles); these are concordant with previous observations.  
 
At E14.5 (Figure 3.4A) the key articular structures are not sufficiently formed enough to be 
distinguishable; however, the femur and tibia are clearly seen. As previously seen in Figure 
3.3, there are a notable number of red puncta (expressing hinge-1 excluded filamin) 
surrounding the cell membrane or sub-membranous region. These cells line the articular 
border of the femur, as indicated by a white arrow. The outer edges from the centre of the 
joint space (indicated again by white arrows) are where the meniscus is expected to form. 
The fluorescence intensity in this area is very low, suggesting that levels of total filamin B are 
low. 
E15.5 (Figure 3.4B) again shows the knee joint. Similar to that seen at E14.5, red puncta are 
evident along the femoral border (indicating hinge-1 excluded filamin B). There are more cells 
in the centre of the joint expressing filamin B than what was observed at the previous time 
point. The triangular shape of what appears to be a forming meniscus is now visible. The 
source and derivation of the cells contributing to the meniscus is unclear. Based on filamin 
expression and tissue shape alone, it could be speculated that filamin B expressing cells may 
be participating in a pre-emptive step in the process.  
 
At the E16.5 time point (Figure 3.4C), the processes that defines the shape and placement of 
the meniscus are well established. Within the joint space filamin expression is low and there 
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are no longer large cellular masses. No red puncta are seen in the joint space or in the 
meniscus as previously observed.  
 
At the first post-natal time point (P2), terminal differentiation of defined structures 
contributing to a developed knee joint is evident. The cell shape and structure of the meniscus 
is very similar to the embryonic time point E16.5 However, there are some subtle differences 
that will be discussed later. At P2 the mechanical forces due to weight-bearing may affect the 
development of the meniscus. P4 shows similar appearances to those that were seen in the 
P2 knee joint. The soft tissues of the joint again show very low filamin expression. 
 
In summary, with the expression of the red puncta in the joint spaces all other expression 
seen of both filamin B alleles is consistent and equal across time points E14.4 to E16.5, 
however, expression begins to decrease from P2. When considering filamin B expression 
within the meniscus, there is a small amount of expression observed at E16. Prior to this, at 
both E14.5 and E15.5, obvious meniscal tissues are not visible. The only other change in 
filamin B expression that can be seen across development is the strong expression in the 
chondrocytes seen from E14.5 to P2; after P2 a decreased expression of Filamin B in 
epiphyseal chondrocytes is observed.  
 
The structures of the meniscus and ligaments become more defined (Figures 3.4C, 3.4D and 
3.4C and 3.4D) as development continues. Filamin B expression reduces over this time series 
in these structures. The endogenous fluorescence is useful in visualising the relative 
expression of both forms of filamin B across the developing joint. However, it is limiting in 
quantifying the absolute amount of expression. In order to address this limitation, 
quantitative data was collected and used alongside the fluorescence data to not only support 
the observations made regarding the expression of filamin B using fluorescence but to 
indicate at what point high and low levels of both hinge-1 inclusive and exclusive filamin B 
forms are present across development. 
 
3.2.1 Quantification of Flnb transcripts 
The detection of the hinge and hinge-1 excluded filamin B can be quantified using quantitative 
PCR detecting both forms of filamin and total filamin across development. The data would 
therefore support the observations using fluorescence microscopy. 
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Six sets of primers were designed and tested, two specifically for Flnb with exon 30 (encoding 
hinge-1) excluded, two specifically for the inclusion of exon 30 and two for detecting total 
Flnb independent of the hinge. Two plasmids containing a section of Flnb from exon 29 - exon 
31 were constructed to validate the primer sets. One construct had exon 30 excluded, i.e. 
exon28-exon29-exon31-exon32, while the second plasmid had exon 30 included, i.e. exons 
28-32 inclusive. These plasmids were constructed to determine whether qRT-PCR primers 
were isoform-specific.  
 




Figure 3.5: qPCR for filamin hinge-1 included and hinge-1 excluded transcripts on control set 
of plasmids. 
Figure 3.5 shows the three primer sets tested on five concentrations of control plasmid DNA 
to form a standard curve, from left to right 0.001ng/µl, 0.0001 ng/µl,  0.00001 ng/µl,  
0.000001 ng/µl and 0.0000001 ng/µl. Panel A shows amplification curves for hinge-1 positive 
detection. Panel B shows curves for hinge-1 negative detection. Panel C shows total filamin B 
detection. Each concentration was done in duplicate with most appearing nearly identical. A 
shows the second replicate for concentration 0.00001 ng/µl had failed, blue arrow. Both B 
and C had the 5th (0.00001 ng/µl) concentration removed due to major inconsistencies and is 
not shown here. 
 
Of the six sets of primers tested, one of each was found to be specific to the respective regions 
for the detection of the two forms of Flnb, as well as one set for detection of total Flnb. These 
primer sets were also checked for their specificity against their corresponding plasmid. This 
was able to show that the hinge-1 detection primers did not produce amplification curves on 
the hinge-1 negative plasmid, as well as the hinge-1 negative primers did not produce 





to check for specificity, they needed to be validated in tissues as a further test of their 
specificity. RNA was extracted from E14.5 whole limb bud tissue and converted to cDNA for 
PCR. In addition to this, RNA was also extracted from cultured cells and a wild type adult 
dermis tissue, since based on observations, expression decreased as mice age.  
  
PCR of qPCR primer sets against sample RNA extracted from cells 
 
Figure 3.6: Filamin B isoform detection test in tissues using the qPCR primer sets 
Figure 3.6 shows the three primer pairs tested on cDNA from E14.5 tissue. Left is a 100bp 
ladder. The bands from left to right show amplification from cDNA at ~450bp. Wild type (WT) 
adult dermis tissues, eGFP/WT tissues from E14.5 limb buds, MEFs from an eGFP/WT and -
RT. The left set of four are for hinge-1 positive detection, Right set is for hinge-1 negative 
detection. 
 
From initial analysis, there was a contamination issue as the -RT sample produced a positive 
result. This indicates that there is most likely a contamination from the plasmid constructs. 
As the primers were designed for cDNA plasmid, contamination appears to be the most likely 
explanation. If this had been successful, the next step would have been to extract tissues of 
interest, such as the ligaments, at the time points examined and measure the RNA transcript 
levels. This proved to be unachievable as these structures were too small. 
 
As the quantitative analysis of the two forms of filamin was unsuccessful, a closer examination 
of the expression of the hinge-1 excluded filamin within the developing joints was deemed to 
be more immediately achievable. Using Z plane imaging, it was proposed that a 3D approach 
could be adopted to better observe expression of hinge-less filamin B since in the foregoing 
analysis there was a clear difference in expression between the two alleles. Additionally, 
higher magnification images could be produced. 
3.3 Hinge-1 excluded filamin B in the joint space 
Hinge-1 excluded filamin B within forming joint spaces in E15.5 knee joint 
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Figure 3.7: Hinge-1 excluded filamin B localises within forming joint spaces in E15.5 knee joint 
Figure 3.7 shows the knee joint space at embryonic timepoint E15.5. This highlighting the red 
puncta indicated by the blue arrows within this area. Panel A is shown along the sagittal plane 
with the top left corner as the distal point of the developing femur indicated by a grey “F”, 
the bottom right corner is the proximal end of the tibia indicated by a grey “T”. Panels A & B 
show red puncta at the centre of the joint capsule of E15.5 mice pups. Both Panel A & C were 
taken at 40x. B is a zoomed magnification of the white box in panel A, D is a zoomed 
magnification of the white box in panel C. C and A are at the centre of the joint capsule within 
the knee joint, however  ~60 micron deeper into the tissue. Filamin B with the hinge present 
is represented as green (eGFP, 488 nm). Filamin B detection independent of the hinge is 
represented as red (mCherry, 568nm). eGFP and mCherry channels merged to show both 
filamin alleles (total filamin B).  
 
Figure 3.7 shows a more detailed analysis of the developing knee of a mouse embryo from 








(hinge-1 excluded filamin B) are clearly evident and that this is the last point before definitive 
intra-articular structures such as ligaments and menisci are observed. 
 
Firstly, red puncta comprised only of hinge-1 excluded filamin were observed at E14.5 and 
E15.5. However, they are more densely clustered at E15.5 in one area, the centre of the 
emerging joint space. The main focus here is on E15.5 as this time point shows a far greater 
abundance of puncta within the joint and they appear more widely distributed than what is 
observed in E14.5. The puncta seen in E14.5 appear more scant and are also observed in P2. 
They are discussed further on in this chapter. 
Upon close examination of the whole knee, femur, tibia and surrounding tissues, these puncta 
are only seen within the developing joint space, suggesting their possible importance for 
development of the joint. As these puncta appear immediately prior to the formation of the 
observable ligamentous structures, it is not inconceivable that their presence is directly 
related to this event. Is is important to note at this point that the puncta were observed in a 
total of 4 mice pups across two sperate litters inciated that this was not an isolated event. 
 
In order to further investigate the puncta, the next logical step is to examine other developing 
joints at this time point. As Larsen syndrome is also known to affect the hips then it might be 
expected that these puncta will be observed in the hip joint if indeed, they are related to 










3.3.1.1 Hinge-1 excluded filamin B across multiple joint spaces 
 
Figure 3.8: filamin B expression across a whole limb at E15.5 
Figure 3.8 shows filamin detection across the whole limb. Panel A is a sagittal section of an 
entire E15.5 mouse limb at 4x. Panel B is a 10x magnification of the mouse hip joint. Panel C 
was taken at 20x magnification at a deeper section of the hip joint. Panel D shows the ankle 
at 20x. The pink arrows indicate areas of red puncta within the joint spaces.  Blue arrows 
indicate the region which is being magnified. Filamin B with the hinge present is represented 
as green (eGFP, 488 nm). Filamin B detection independent of the hinge is represented as red 
(mCherry, 568nm). eGFP and mCherry channels merged to show both filamin alleles (total 
filamin B). 
 
By mapping the whole limb, as shown in Figure 3.8,  the puncta can also been seen in other 
joint spaces including both the hip and the ankle between the tibiotaral and tarsometatarsal 
bones. These hinge-less filamin B puncta are also only observed at the time point E15.5. Prior 
to this, the puncta appear less abundant and are closely associated with the chondrocytes of 
the forming bones. Following E15.5, the puncta are exclusively observed in epiphyseal 
chondrocytes and are far more sparsely spread than observed within the joint space at earlier 
timepoints.  
A 
B C D 
 52 
With the supporting figure, It is possible then that the observed red puncta may represent a 
critical cellular structure important for the formation of the ligaments. To further explore this, 
30-100 micron thick sections were evaluated using confocal microscopy to see how these 
structures would appear in 3D space. 
 
Still image of VIDEO-1 – Figure 3.9 (see attached file) 
 
Figure 3.9: 3D construct of cells within the knee joint at E15.5 showing hinge-1 excluded 
filamin B 
Figure 3.9 shows a 3D diagram of cells within the knee joint at E15.5 showing red puncta cells 
within the joint spaces. Filamin B with the hinge present is represented as green (eGFP, 488 
nm). Filamin B detection independent of the hinge is represented as red (mCherry, 568nm). 
eGFP and mCherry channels merged to show both filamin alleles (total filamin B). 
 
 
The 3D construct clearly shows a large amount of hinge-1 excluded filamin B (red puncta) that 
appears to be sitting in or just below the cellular membrane (associating with the 
cytoskeleton) in cells that are expressing hinged filamin at a low level (represented as yellow). 
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These images show that a large amount of the hinge-1 excluded filamin B is present in a 
relatively large ball-like structure referred to as puncta. These are observed at multiple points 
located at the periphery of the cytoplasm in a juxta cellular membrane distribution. 
 
As it is unclear what cells differentiate into the ligaments and meniscus, it cannot be 
determined for certain what cells the red puncta occur in. Therefore a series of histological 
stains were preformed to attempt to identify the forming ligaments before they present as 
definitive structures by looking for large section of collagen.  
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Hematoxylin and eosin histological stains of P5 mice showing the meniscus and the ligaments
 
Figure 3.10: H&E histological stains of P5 mice 
Figure 3.10 shows a (H&E) stain of P5 tissues sectioned along the sagittal plane. Panel A shows a 4x 
magnification of a knee section, B shows this section at a 20x magnification. The black arrows indicate 
the meniscus. Panel C shows a 4x magnification of a knee section of the same knee joint at a different 
depth in the tissue sectioned, Panel D is the same section at 20x magnification. The green arrows 
indicate the ligaments within the knee joint.  
 
These tissues appear similar to findings of (Khorasani et al., 2015) and support the 
identification of the structures. A tri-stain for cartilage, collagen and muscle was prepared 
and optimised on P2 tissues. However optimising proved practically difficult for earlier time 
points as the tissue was easily washed away due to its small size and easily over/under 





Moving on from histological stains and looking back at the red puncta within the centre of the 
joint space and in some cells, it seems that a distinct pattern of expression of filamin B is 
associated with the developing ligament seen in Figure 3.3.  Furthermore it was also observed 
that filamin B is expressed at the ligament attachment points, also referred to as entheses. 
 
3.4  Chapter summary 
 
In the developing tissues of the E14.5 to P4 mice, it was observed that expression of both 
alleles of filamin B were present. It was shown that hinge-1 included filamin B is abundant 
across all timepoints and is found far more abundantly than the hinge-1 excluded form. The 
hinge-1 excluded forms appears to be found in higher amounts as small puncta within the 
cells rather than distributed throughout a whole cell. Interestingly the hinge-1 excluded form 
appears to be regulated during development, confined to the joint spaces and was observed 
most abundantly at E15.5. 
The cells seen in the tissues that possess the red puncta are difficult to both count and 
quantify. It is observed that they are present at least one per cell, however the quality of the 
imaging for tissues sections at this thickness and magnification are insufficient to more fully 
characterised their distribution. A method with higher resolution to track and observe these 
structures is required to understand their appearance and distribution during development. 
It was also observed that between E15.5 and E16.5 there is a very abrupt and major shift 
towards development of the ligamentous and meniscus structures, which coincidentally, may 




4 Filamin B in developing cells of joint soft tissues 
 
As filamin was observed across development in both the ligaments, menisci and 
chondrocytes, cell shape changes were also observed. In this chapter these observations can 
be extended further, with particular focus on structures such as the entheses. 
 
4.1 Filamin B expression in the Ligaments  
Ligament enthesis (attachment point) to the tibia at P2 
 
Figure 4.1:Ligament attachment point to the tibia at P2. 
Figure 4.1 shows the ligament attachment point (the enthesis) observed at time point P2. Panel A, 
filamin B detection independent of the hinge, (mCherry, 568nm). Panel B, filamin B with the hinge 
present, (eGFP, 488 nm). C, all channels merged with cell nuclei are labelled with DAPI, 358nm. D, 





circle shows the ligament indicated by longer cell shapes. The pink dotted line indicates the enthesis 
characterised by cells with a round shape.  
 
 
Due to the finding of hinge-less filamin B specifically when the ligament is forming seen in 
Figure 3.3, I focused on different aspects of ligament structure, such as the shape of the cells 
and cell count. Where the ligament attaches to the bone (Figure 4.1), we can see that the 
elongated cells along the border of the distal edge of the bone (left side of image) have lower 
fluorescence, while the rounder cells on the right show more fluorescence therefore 
indicating a greater abundance of filamin B. It can also be seen that the cell shape changes 
from elongated cells, within the body of the ligament, to more rounded, shortened cells at 
the margin of the bone. There is then a progression in form, from tightly packed round cells 
to more spread out cells, that make up the enthesis.  
Unlike the previous time points, particularly E15.5 there are no puncta observed. However, 
as the ligaments have formed and attached to the bone, it is noted that these cells still express 
both forms of filamin B. It is an important consideration as these are not only where the cells 
showing large amounts of the red puncta might have migrated to but, this may also indicate 
a weakness point for the cause of joint dislocations seen in Larsen syndrome. 
 
As the ligament develops, especially postnatally, changes are seen in the cell shape within the 
ligament (Figure 4.1). The cells go from a round tightly packed group to a more spread, 
organised and  elongated formation, appearing like bricks (Figure 4.1B). This elongated brick 
like shape of the ligament cells have been seen previously (Benjamin & McGonagle, 2009).  
The expression of filamin B during this time pre to postnatal transition is high  in the ligament 
and clearly visible, occurring in conjunction with the animal beginning to bear weight ex utero. 
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4.1.1 Ligament cell shape change from prenatal to postnatal 
  
Figure 4.2: Ligament cell shape change from prenatal to postnatal 
Figure 4.2 Shows the ligaments within the knee joint at timepoint P2 and E16.5. The images are from 
sections cut along the sagittal plane; the joint is orientated with the femur in the top left corner 
indicated by a grey ‘F’ and the tibia at the bottom right indicated by a grey ‘T’. Panel A & B is at time 
point P2, with panel A showing cell numbers indicated by DAPI. 
Panel C & D is at time point E16.5, with panel C showing cell numbers indicated by DAPI The ligaments 
are indicated by white arrows. The red circles indicate the more long-block shaped ligament cells are 
seen. The pink circles show where the more rounded shaped ligament cells are seen. Filamin B with 
the hinge present is represented as green (eGFP, 488 nm). Filamin B detection independent of the 
hinge is represented as red (mCherry, 568nm). eGFP and mCherry channels merged to show both 
filamin alleles (total filamin B). 
 
There are clear changes in both cell shape and cell density between prenatal (E16.5) and 
postnatal (P2) ligaments (Figure 4.2). Between E16.5 and P2 the cellular mass that forms the 








more spread out field of cells. The shape of the cells themselves also appear to change 
between E16.5 to P2, changing from round cells to becoming more elongated block-like cells. 
The fluorescence of the P2 cells also shows a moderate increase in filamin B expression from 
the levels observed at E16.5 indicating that filamin is also important in post-natal 
development. This could possibly be in response to external weight pressure or stress on the 
ligaments. 
 
Because of the observed changes in ligament cell shape, it was deemed equally as valuable 
to study the same unit in the developing meniscus, as the cells with the red puncta seen in 
E15.5 may also relate structurally to meniscus development. 
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4.1.2 Comparison of prenatal and post-natal meniscus expression of Filamin B 
 
Figure 4.3: Comparison of prenatal and postnatal meniscus expression 
Figure 4.3 Shows the meniscus within the knee joint at timepoint P2 and E16.5. The images are from 
sections cut along the sagittal plane; the joint is orientated with the femur in the top left corner 
indicated by a grey ‘F’ and the tibia at the bottom right indicated by a grey ‘T’. Panel A and B are at 
time point E16.5. The menisci are indicated by the white arrows. The red circle shows cells within the 
menisci that are rounded and close together.  
Panel C and D are at time point P2. The menisci is indicated by the white arrows. The pink circle shows 
meniscal cells with a more stared (spiky) appearance, these cells also appear more sparsely spread. 
The lower structure indicated by a blue arrow is the patella tendon. Filamin B with the hinge present 
is represented as green (eGFP, 488 nm). Filamin B detection independent of the hinge is represented 
as red (mCherry, 568nm). eGFP and mCherry channels merged to show both filamin alleles (total 
filamin B). 
 
The postanal meniscus shows a more developed cell shape change when compared to the cell 










ligaments (Figure 4.3). The cells in the prenatal meniscus appear both rounded in shape and 
tightly packed, while the postnatal meniscus shows more spread out cells with a star like 
appearance.  Between E16.5 and P2 it appears that these cells spread out, appearing in fewer 
numbers and adopt this stellate shape. The fluorescence level of the filamin however does 
not appear to change, indicating that filamin B is important for meniscus development 
throughout these time points.  
 
An important observation was made relating to the blood vessels seen in relation to the 
developing meniscus. There is strong filamin B expression in the vascular structures as 
expected (Valle-Pérez et al., 2010), indicated by the blue arrow in Figure 4.4. The location of 







4.1.2.1 Elevated levels of filamin B are present in the blood vessels of the knee joint  
 
Figure 4.4: Elevated levels of filamin B are present in the Blood vessels of the  knee joint 
Figure 4.4 shows a tissue section from a P4 meniscus that has been cut in the sagittal plane 
with the meniscus in the centre. A blood vessel is indicated by a blue arrow and is found near 
the periphery of the meniscus. The femur (F) is to the left; the tibia (T) on the right.  
Panel A, filamin B with the hinge present, (eGFP, 488 nm). Panel B, filamin B detection 
independent of the hinge, (mCherry, 568nm). C, all channels merged with cell nuclei are 
labelled with DAPI, 358nm. D, eGFP and mCherry channels merged to show both filamin 
alleles (total filamin B).  
 
The blood vessels within the meniscus of the P4 pup show very high filamin expression of 
both alleles. The expression of filamin along the chondrocytes of both the femur and tibia 
show a reduced level of filamin B expression compared to P2, as well as a tighter, more packed 






To further investigate the localisation of filamin B within the cells showing juxta membrane 
expression of filamin B puncta, higher magnification images of 40x and 60x were captured. 
 
4.2 Cellular localisation of filamin B 
Filamin B is able to crosslink actin within the cytoskeleton. Using the same imaging 
techniques, chondrocytes were imaged as these were not only abundant within the samples 
but also expressed filamin B abundantly. 
 
Cellular localisation of both filamin B alleles in E16.5 mice 
 
Figure 4.5: Cellular localisation of both filamin B alleles in E16.5 mice 
Figure 4.5 shows filamin B distribution in chondrocytes cells at E15.5. Panel A was taken at 
60x and B is 1.5x zoom. Panel C was taken at 20x and panel D is 2x zoomed. Panels A & B were 




Filamin B with the hinge present is represented as green (eGFP, 488 nm). Filamin B detection 
independent of the hinge is represented as red (mCherry, 568nm). eGFP and mCherry 
channels merged to show both filamin alleles (total filamin B). 
 
Filamin B is present more abundantly (as depicted by high fluorescence levels) at the cell 
membrane with lesser fluorescence observed inside the cell. This is also evident in Figure 4.6, 
which is a reconstructed model of a z-stack of images from the same tissue block imaged in 
Figure 4.5. In the upper two panels of the Figure 4.5 A & B, filamin B can again be seen clearly 
outlining the cell membrane. There is also some evidence of bleed through as shown by the 
paler levels within the cell. This is likely due to the increase exposure that was used as after a 
few minutes of imaging the samples began to bleach and fluorescence was lost. In addition, 
some cells have red puncta (hinge-1 excluded filamin B) on what appears to be the cell 
membrane or sub-membranous region (Figure 4.5).  
 
The bottom two images of Figure 4.5 C and D show chondrocytes with filamin expression at 
what appears to be the cellular membrane. The red puncta are also observed here. These 



















Still image of VIDEO-2 – Figure 4.6 (see attached file) 
 
Figure 4.6: 3D construct of cells showing filamin B 
Figure 4.6 shows a 3D construct of chondrocyte cells within the developing femur of E15.5 
mice. Filamin B with the hinge present is represented as green (eGFP, 488 nm). Filamin B 
detection independent of the hinge is represented as red (mCherry, 568nm). eGFP and 
mCherry channels merged to show both filamin alleles (total filamin B). 
 
In addition to the presence of filamin B at the cell membrane, filamin B can also be seen in 
the cleavage furrow, this is when the cell membrane begins to indent, as the cell begins 
cleaving into two. As filamin B is known to be observed here (Nunnally et al., 1980), this 
further validates the model used in this study. However, this may also support experiments 
to understand the functions of the red puncta further. As there is a large amount of filamin 
seen within the cleavage furrow and the filamin puncta are observed in some cells with the 
furrow (assuming there are occasions where the tissue has been section so that some are not 
observed) there may be some relation to the cell divisional orientation and/or migration and 
the red puncta.  
 
To gain some further evidence that that red puncta might be polarising the cells and that 
filamin B is highly expressed along the cleavage furrow, the cells at the dividing chondrocyte 
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columns within the epiphyseal growth plate were examined more closely. These columns rely 
on this polarised division and are oriented along the long axis of the bone and cell division 
occurs to preserve this orientation of chondrocyte columns within the epiphyseal growth 
plate.  
 
4.2.1 Filamin B is present in the cleavage furrow of dividing cells at P2 
 
Figure 4.7: Filamin is present in the cleavage furrow of dividing cells 
Figure 4.7 shows filamin B presence in the cleave furrow of chondrocytes at time point P2. 
Panel A shows filamin B with the hinge present, (eGFP, 488 nm). Panel B shows filamin B 
detection independent of the hinge, (mCherry, 568nm). Panel C, eGFP and mCherry channels 
merged to show both filamin alleles (total filamin B). D, all channels merged with cell nuclei 





A 40x magnification and the images enlarged by 2x, this presents the cells in a way that clearly 
shows the division. Figure 24 is taken from a mouse at P2 and depicts growth plate 
chondrocytes. This validates the mouse models used in this study, as filamin is well known to 
be involved in cell division, specifically, the cleavage furrow in these cells. The cleavage furrow 
can be clearly seen between the two nuclei.  
 
 
4.2.2 Cells displaying the hinge-less filamin B protein indicated as red puncta present at the 
dipoles 
 
Figure 4.8: Cells displaying the hinge-less filamin B protein indicated as red puncta are present 
at the dipoles 
Figure 4.8 shows the total filamin B expression form P4 chondrocytes at 40x. The purple arrow 
depicts the cellular cleavage furrow. The green arrows indicate hinge excluded filamin B 
puncta. Filamin B with the hinge present is represented as green (eGFP, 488 nm). Filamin B 
detection independent of the hinge is represented as red (mCherry, 568nm). eGFP and 




Green – eGFP 
Red – mCherry 
Blue – DNA (DAPI) 
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Figure 4.8 indicates that filamin B with hinge-1 excluded may be involved in cell division as 
on this particular plane it appears that the spots are located at the cellular dipoles.  
This image was produced on the inverted microscope. A precise slice image could not be seen 
and it is therefore not possible to determine the exact number of spots per cell and their 3D 
location relative to the nucleus. These cells show an increased amount of hinge-1 excluded 
filamin B as indicated by the red spots. Where there is an evenly distributed amount of hinged 
filamin B there is also an equal amount of hinge-1 excluded filamin. However, overall these 
cells show a higher amount of hinge-1 excluded filamin B compared to the hinge inclusive 
one. 
 
An experiment on primary cells cultured from these animals was designed to examine if these 
puncta would co-localise with cell division dipole markers such as the centriole specific 
marker gamma-tubulin using immunohistochemistry. This is a protein that is found at the 
centriole and required for microtubule formation. Furthermore, if there were multiple puncta 






4.2.3 filamin B expression in MEFs cultured from filamin B-cherry mice 
Immunohistochemistry of MEF’s using mCherry antibody and Gamma tubulin 
 
Figure 4.9: Immunohistochemistry of MEF’s using mCherry antibody and Gamma tubulin 
Figure 4.9 shows Immunostaining of MEFs. These obtained from the mouse line and tested at 
passage 7. Panel A is stained with anti-mCherry antibody, (red, 594nm) exposure time 
(800ms). panel B is stained with anti-gamma-tubulin antibody with a green secondary, 488nm 
measured at double exposure time (1600ms). Panel C is stained with DAPI exposure time 
(33ms). Panel D is all three channels over laid. 
 
 
Embryonic fibroblasts were collected from timepoint E14.5 and used in the following 
immunofluorescent experiments. Antibodies were optimised for immunocytochemistry on 
cultured cells. An anti -mCherry antibody was also used as this could then potentially be used 
on tissue sections already obtained to restore fluorescence, as the fluorophore will bleach 
over time.    
 
Gamma tubulin is associated with microtubule formation in cell division. When examining the 
example Immunostaining images provided by the company, the staining here shows 
nonspecific antibody binding for both gamma tubulin and mCherry. Furthermore, the 
antibody was undetectable at 400ms, which is the exposure used for mCherry in the tissues 
A B 
C D 
Red – Gamma Tublin Green – mCherry 
Blue – DNA (DAPI) All Channels Merged 
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samples and was still undetectable at double the exposure, 800ms. Despite optimisation of 
the gamma tubulin, no detection was witnessed and no subsequent co-localisation was 
observed. 
 
4.2.4 Immunostaining localisation of filamin B and actin in MEFs  
Immunostaining of filamin B and actin in MEFs  
 
Figure 4.10. Immunostaining localisation of filamin B and actin in MEFs.  
 
Figure 4.10 shows Immunostaining of MEFs. These were obtained from the mouse line and 
tested at passage 8. Panel A is stained with phalloidin (488nm) antibody for alpha actin 
detection exposure time 250ms. Panel B is stained with anti-MCherry antibody (594nm) 
exposure time 250ms. Panel C is DAPI stained exposure time 55ms. Panel D is all three 
channels over laid. 
 
 
Phalloidin detected actin successfully in the MEFs. However, as previously mentioned, the 
staining shows nonspecific antibody binding for the anti-MCherry antibody as the wild type 
cells with no mCherry tag look identical, no successful detection was seen. Therefore it is 




Green – Alpha actin Red – mCherry 
Blue – DNA (DAPI) All Channels Merged 
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Following this cells were observed in live tissue culture to check for endogenous fluorescence 
and none was detected. It was found that in order to maintain endogenous fluorescence, the 
MEF’s had to be of a low passage (passage 4 and under). Subsequently live-cell imaging of 
these cells was carried out.  
 
4.2.5 Hinge-1 excluded filamin B in live MEFs cells  
Hinge-1 excluded filamin B in live MEFs cells  
 
Figure 4.11: Hinge-1 excluded filamin B in live MEFs cells  
Figure 4.11 shows cultured filamin B MEFs cells at passage number 4. Panel A is filamin B with 
the hinge present, (eGFP, 488 nm). Panel B is filamin B detection independent of the hinge, 
(mCherry, 568nm). C, eGFP and mCherry channels merged to show both filamin alleles (total 
filamin B). Panel D is 1 cell at a higher magnification, images A, B and C were taken at 60x 
and D is zoomed by 1.4x. The white arrow indicated the hinged inclusive filamin B allele and 






Figure 4.11 shows that the cultured MEF cells at a lower passage do express fluorescent 
filamin. There is an obvious expression difference between the two filamin alleles. While 
hinge inclusive filamin shown by green is cell-wide in its distribution as seen in mouse tissue, 
total filamin indicated in red only, appears to be present associated with an unknown cellular 
structure. As mCherry is indicative of total filamin it should be present in all areas eGFP 
(green) is observed, but however it is not.  
 
Due to the observations form the MEF’s the most likely reason the puncta are seen here is 
something anomalous with the engineered filamin B allele. This could be cleavage for the 
mCherry tag from filamin B protein and that what is being observed in the tissues is different. 
As the red puncta seen in the tissues are very specific to the developing joints and are far 
fewer in number than what is observed in culture, the appearances of mCherry tagged filamin 
B in these cells likely depicts a different phenomenon such as instability of the tagged filamin 
B protein. 
 
In order to understand the differences between the appearance of the mCherry tagged 
protein in the MEFs and that observed in vivo in the developing joints, a western was carried 
out. A western blot would show the size of the protein and could determine if the mCherry 
tag was being cleaved off the filamin B protein. The molecular weight of filamin B is 278kDa, 
the mCherry fluorophore is weights 26.72 kDa, therefore the total filamin B protein with 
mCherry would weight 304.72 kDa. This is an extremely large protein, which would be 
challenging to evaluate by this technique. 
 
The initial plan for the Western was to run this in a gradient gel of 2% and 10%, as the 
potential products would be between 26kDa and 305kDa. This would have the potential to 
produce 3 bands, mCherry + filamin B, mCherry exclusively and filamin B exclusively. If filamin 
B was detected at 278kDa indicated by the ladder or did not co-localise with the mCherry 
antibody it would give validity to a cleavage event. If a protein was detected at ~305kDa it 
would indicated no cleavage and that hinge-1 excluded filamins was aggregating. 
 
Unfortunately the first trial did not work and produced no bands other than the ladder and 
time constraints prevented further refinement of this technique to answer this question.  
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4.3 Chapter summary 
As observed in Figure 4.5 the majority of filamin B expression (hinge-1 included) is in or just 
below the cell membrane. Interestingly closer examination of the tissues has also shown that 
the red puncta (hinge-1 excluded) also appear to be located in a similar position. In addition 
filamin B was also observed in the cleavage furrow of dividing cells as a bright yellow band 
indicating that both filamin B alleles are located to this structure. Further experimentation to 
co-localise the red puncta with gamma tubulin in cultured cells was unsuccessful. In addition 
attempts to demonstrate co-localisation of the actin cytoskeleton with the filamin B 
containing puncta were unsuccessful. It was observed that in cultured cells, N-terminal tagged 
filamin B  did not co-localise with hinge labelled filamin B possibly indicating a cleavage of the 
mCherry tag from the former protein. However because this was only observed in culture, 
the observation of the distribution of these two alleles in vivo may still be valid and represent 






5.1 Filamin B total expression  
As development progresses, it has been observed across all time points (E14.5 to P4), that 
filamin B is expressed in the mouse limb. It is known that when filamin B is knocked out, there 
are a multitude of downstream disruptions to development from spinal segmentation to limb 
development (Krakow et al., 2004). My findings confirm the presence of filamin B in the lower 
limb across all observed time points. During this timeline, both forms of filamin B (hinge-1 
inclusive and hinge-1 exclusive) are found. I observed that filamin B is present prominently in 
the developing chondrocytes with the hinge-1 present.  
 
5.1.1 Inclusion and exclusion of hinge-1 in development 
Other than the red puncta observed in Figure 3.3B, no other discernible difference in the 
distribution of filamin B hinge-1 inclusive or exclusive, was detected in developing tissues. The 
levels of both alleles appear to be expressed constantly throughout development; however, 
there are changes in the overall expression of filamin B. As development progresses in the 
prenatal timepoints, the ligaments have a lower expression of filamin B when compared to 
the chondrocytes (Figure 3.4C). After birth, the postnatal timepoint P2 shows a higher 
expression compared to prenatal ligaments. This could be due to a number of reasons, but 
the most obvious is that the mice are no longer suspended in amniotic fluid and their limbs 
are now subjected to force, as they begin to bear weight. This is particularly interesting as 
filamin A is known to have mechanosensitive properties (T. Luo et al., 2013) and my results 
suggest that filamin B may also have a similar role as previously indicated by Schiffhauer & 
Robinson, 2017. This could possibly explain the increase in expression in response to 
increased weight-bearing observed in Figure 3.3C, indicating a developmental step to 
strengthen the ligaments further. This is then following by a significant decrease in expression 
of both filamin B alleles in both the chondrocytes and the ligaments seen in Figure 3.3E. The 
decrease in chondrocyte filamin B expression is most likely due to mineralisation as this 
begins after birth (Patton & Kaufman, 1995). As expression also drops in the ligaments, 
although it is still quite cellular, this may also be a result of the terminal development of the 
ligaments as necessary structures in the ligaments and the tissues reach their definitive state. 
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5.1.2 Critical development point 
The most compelling finding of my study was the observation that there is a significant 
amount of hinge-1 excluded filamin B present at E15.5, immediately prior to when the 
ligament can be detected visually within the center of the joint capsule (Figure 3.3C). This 
appears to be where the ligaments might attach to the bone, the enthesis (Benjamin & 
McGonagle, 2009).  Although the puncta appear in the center of the joint cavity between the 
two forming bones in a small oval shape, they appear closer to the femur and not across the 
whole joint space as we might expect if they were forming the whole ligament. It is also 
important to consider that at this point that there is only one time point before and one after 
the point where this phenomenon is observed. Additional research might focus on capturing 
this entire process between E15.5 and E16.5 by increasing the number of embryos 
investigated during this period, in order to fully understand how these structures form, as this 
is not currently understood. Understanding this coupling with how both forms of filamin B 
are involved may contribute to understanding how the variants seen in filamin B cause joint 
dislocations. 
 
5.2 Joint development 
To identify the forming ligaments and track their development, a tri-stain that stains collagen, 
elastic fibres and cartilage was used. This was to be done across all time points to help 
determine when and where the ligaments first begin to form by observing where collagen 
first appears and subsequently migrates to. This would have been most critical about E15.5 
to E16.5 (Figure 3.3B & 3.3C) to identify the boundaries of the forming ligament and meniscus. 
This could then corroborate the findings with the H&E stain to show that the structures 
observed early on were, in fact, the ligaments and meniscus. However, this proved to be 
difficult to do across all time points due to limited time. 
 
During development, I observed that the time point between E15.6 and E16.5 is the critical 
point at which the cruciate ligaments form. This is clearly seen in the area between the femur 
and tibia where cells that begin evenly distributed throughout the space, condense into 
ligament shaped bands that cross from the tibia to the femur shown in Figure 3.3B and 3.3C. 
These shapes are very similar to ligaments seen in adult tissues and resemble what is seen in 
the H&E stains from P5 tissue, Figure 3.10C. I therefore conclude that the crucial timepoint 
for ligament formation is between E15.5 and E16.5 and filamin B hinge-1 excluded isoform is 
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critical here. Additionally, at this point, the meniscus becomes tangible and shows the 
triangular shape that identifies this when viewed from the sagittal plane as seen in Figure 3.4. 
 
5.2.1 Meniscus development 
At the early points of development studied here (E14.5), a low amount of filamin B is detected 
in the areas of the joint the mature ligaments and menisci will inhabit. Once the meniscus 
shape is distinguishable, the tissue shows low filamin B expression and this remains consistent 
across all recorded timepoints (Figure 3.3 & 3.4). While filamin expression is present, it is not 
as high as seen in the chondrocytes. Furthermore, the tissues show no difference between 
the two filamin B alleles. Very high filamin B expression seen is within the blood vessels of the 
meniscus, as was expected (Valle-Pérez et al., 2010; X. Zhou et al., 2007). 
 
As the observed expression in the meniscus appears lower and less variable than what was 
observed in the ligaments, it is possible that the pathological variants seen in Larsen 
syndrome might not affect this tissue, as no hinge-1 regulation can be observed in the 
developing tissues. Therefore, the meniscus could be less likely to be a major contributor to 
the joint instability seen in Larsen syndrome.  
 
To fully understand and validate these findings, it would be prudent to analyze  histological 
sections of an individual’s meniscus to compare shape and development, with RNA 
quantification of filamin B during development. Fukazawa et al., 2009 began to examine the 
meniscus across a multitude of age groups and this would provide a good position to start 
from when looking at how an expression changes across the life of the meniscus. This would 
provide critical information on how the meniscus appears to develop and would be a good 
direction to continue the research for joint development related to Larsen syndrome. 
Histological staining was preformed and optimized for the embryonic tissues called a  tri-stain 
This stains the cartilage within the tissues an orange to red colour, the muscle tissue pink and 
the collagen fibers blue. This would have helped to determine cell differentiation points in 
the developing knee particularly in the ligaments with the detection of collagen and would be 
essential at time point E14.5. However this as each staining method needed to be adjusted 
slightly for each time point time restraints limited this from being completed.  
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5.2.2 Ligament development  
The red puncta observed appear to be unique to the joint spaces, as shown in Figure 3.3B, 
showing ligament development and particularly well in Figure 3.7B and 3.7D. As the knee is 
not the only joint that possesses ligaments, the next logical step would be to determine 
whether these puncta are present in other joints that have ligaments including the hip, which 
is also known to be dislocated in Larsen syndrome.  My data (Figure 3.8) show that both the 
hip and ankle joints also have red puncta at E15.5 (labelling hinge-1 excluded filamin B), 
further supporting the theory that hinge-1 excluded filamin B  is involved in the formation 
and differentiation of ligaments. 
 
The puncta are small collections of filamin B that do not have hinge-1, that are found in a 
small population of cells in key areas. Despite the expectation that the hinge-1 excluded 
filamin B would be seen in this model, it was surprising that it was very specific to the joint 
spaces within the knee of E15.5 mice. This gave rise to an initial theory that this hinge-1 
excluded filamin B might potentially affect the ligaments in a similar way to that seen in 
filamin B pathologies, as hypothesised. This initial theory was strengthened by data from 
E15.5 shown in Figure 3.3B observing the lack of green signal, but again at E16.5 which show 
not only a mass of cells between the two bones but a clearly defined and somewhat obvious 
ligamentous structure between the bones resembling what is seen in a fully developed adult. 
This was a strong indicator that the two events red puncta observation and ligament 
formation could be related as the puncta were observed immediately prior to the ligaments 
(Figure 3.3B) first being observed. These red puncta could support stronger actin linking their 
role in the formation of ligaments as a strong tensile resistant structure is possible.  
 
These red puncta were also observed within the chondrocytes, mostly at the P2 time point. It 
is worth noting that this time point is the last point before filamin B begins to show less 
expression indicated by lower fluorescence. This is similar to what I observed in the joint 
spaces; expression of hinge-1 excluded filamin B prior to the formation or strengthening of 
structures. The puncta are seen here right before the bones begin ossifying, not in the same 
numbers and abundance seen on the joint spaces, but are still observed in high numbers and 
could be part of the final step in strengthening and building bones. I postulate that the 




Previous reports have shown that filamin B is present during segmentation of the vertebra 
(Krakow et al., 2004) in young mice. As part of this investigation of filamin expression, the 
vertebra of P2 mice was also examined for expression of the two filamin B alleles. It was found 
that the chondrocytes in the vertebra appeared identical to those seen in both the femur and 
tibia and no exclusive hinge-1 excluded filamin B was seen. However, in light of the 
observation at E15.5, it would be paramount, that if this study was repeated, to examine the 
spine for the red puncta, indicative of hinge-1 excluded filamin B. As observed in the leg joint 
spaces, it is likely that hinge-1 excluded puncta would be observed here as a strong fibrous 
connection (the intervertebral discs) between the vertebra is important. Furthermore, 
phenotypes involving the vertebra of Larson syndrome individuals (Bicknell et al., 2007) 
would implement a hinge-1 related filamin B effect here. 
 
5.3 RNA detection of filamin B 
The discovery that the red puncta are thus far only observed in the joint spaces is particularly 
notable as this may not have been detectable from RNA studies alone. While this was planned 
to quantify the amount of transcript, the presence of RNA would only indicate the relative 
proportion of hinge-1 excluded filamin B present. It would not provide data as to whether it 
is present as puncta within cells rather than being dispersed throughout the whole cell. This 
is why it is important to use both approaches. 
Using RNA to quantify the amount of filamin B was also an important step in corroborating  
 what was inferred by fluorescence. Although it is possible to quantify the amount of filamin 
B present in the cells and tissues based on fluorescence  (Hamilton, 2009; Rizk et al., 2014)  
using the level of nuclear staining as a control, it would be better and more accurate to also 
measure each transcript.  
 
5.3.1 RNA quantification 
The use of RNA quantification was an option to analyse tissues that express different levels 
of the filamin isoforms and could therefore potentially indicate which tissues are most 
adversely affected in these filamin B syndromes. These tissues proved to be extremely 
difficult to both isolate in the prenatal mice  and extract RNA from despite using products 
designed to extract RNA from small samples. Several attempts were made to improve this, 
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The extraction of RNA with the use of a specialised kit that is designed for small tissue samples 
however this also yeiled little RNA as adult ligaments that were able to be extracted, lacked 
the quantity of cells to produce a usable about of RNA. In addition to this an attempt to culture 
the  cells was also done. However, liberation of the cells and growth of the these cells and 
others like them was unsuccessful and would not have been expressional accurate as tissue 
culture changes the environment. It was for this reason that RNA quantification of both the 
filamin B isoforms was unable to be completed. 
 
Moving forward (while difficult) RNA quantification data would be an extremely useful aspect 
in continuing this work. Laser tissue capture from tissues and obtaining the desired structures 
like the ligaments as discussed by (Farris et al., 2017) may be a better alternative solution for 
this while utilising an RNA extraction kit designed for small RNA samples.  
 
5.4 Red puncta (Hinge-1 excluded filamin B) 
One of the main objectives for these experiments was to look at where, how and when the 
two forms of filamin B were expressed and to hopefully determine why hinge-1 is important 
for the development of these structures and how variants surrounding the hinge-1 may lead 
to the Larsen syndrome phenotype. From the experiments, it was observed that hinge-1 
excluded filamin B is not common across the leg of the mouse; in fact, it was only rarely 
observed. Hinge-1 excluded filamin B was only observed between bones in the joint spaces 
and only during very narrow timepoint ranges: it was present at E15.5 but was gone at the 
next time point (E16.5).  
 
The hinge-1 excluded filamin B was observed as small red puncta appearing at the cell 
periphery within the cell. I previously hypothesised that I might discover a cell population that 
only expressed hinge-1 excluded filamin B and that this allele could be transient depending 
on where the cell is in time and space. Such a population might represent the ligament 
progenitor cells.  
 
5.4.1 Puncta observed in culture 
We know that the red puncta seen in culture are different from what is observed in tissue 
from three aspects. Firstly, as per Figure 3.7 and Figure 3.9 in tissue, it can be clearly observed 
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that the red puncta appear as large and defined circular spots in several positions of the cell. 
Although it is unclear whether these are within the cells or on the cell membrane, it is likely 
to be membrane adjacent, as indicated but the 3D model of the cells seen in tissue.  
Secondly, in the cultured MEF cells seen in Figure 4.11, there appear to be many smaller, red 
puncta which are more dispersed than those seen in the tissues, Figure 4.11 . These puncta 
also appear to be more perinuclear than what has been previously observed, suggesting 
expression in the endoplasmic reticulum, Golgi or similar, although this was not specifically 
tested for.  
Thirdly, in the tissues it can be seen that when both forms are present in a cell, indicated by 
green and red, they are expressed together, close to the cell membrane connecting to the 
actin network (clearly seen in Figure 4.5 ). Whereas in culture, the two forms are independent 
of each other, eGFP appears to represent the cytoskeleton and the red puncta can only be 
seen surrounding the nucleus. The two forms do not colocalise as seen in the tissues, nor do 
the red puncta appear to be associating with the cell periphery. Additionally, the argument 
can be further strengthened as the only puncta seen in the tissues are confined to the joint 
spaces at very specific time points, immediately prior to the ligament formation.   
 
The puncta in cells therefore do not appear similar to those seen in tissue. Consequently, it 
may be, that the mCherry fluorophore tag is being cleaved off the filamin B protein in vitro, 
allowing for its accumulation as puncta, adjacent to the nucleus as observed in these cells. 
This would have been identified by a western blot. 
Filamin B puncta have been observed before within cultured cell lines by Daniel et al., 2012. 
These appear to be different from what is observed in the MEF cells lines in this study, as 
these appear smaller and in larger numbers per cells than observed in the previous study. 
Although this could be an observed problem with the filamin B mouse model, the puncta seen 
in the mice are very specific to the joints and very specific to that time point of E15.5. The 
results from tissue indicate co-localisation of filamin B with actin. I did attempt to colocalise 
these puncta with the actin cytoskeleton in culture, however the cultured cells not only 
appeared differently, but the immunostaining could not be optimised in sufficient time. 
Immunostaining of the tissues samples was planned for however, as the tissue culture was 
the first step in testing this colocalization but the experiment did not progress this far. 
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The differences observed between the cultured cells and the tissue cells can most likely be 
attributed to a variation in expression resulting from cell growing conditions, as they both 
derived from the same source.  
 
5.5 Filamin B in Larsen syndrome  
The gain of function mutations seen in filamin B that produce Larsen syndrome are often 
located immediately surrounding the hinge-1 region of the protein or in the CH2 domain 
(Daniel et al., 2012). This was the initial finding that lead to the investigation of hinge-1 
exclusion and inclusion, as the hinge-1 can be alternatively spliced; more so, how a gain of 
function variant may influence the inclusion of hinge-1 and how this would lead to the 
phenotypes seen, such as these unstable joints. I hypothesised that the phenotypes observed 
could be due to the soft tissues of the joint failing to develop correctly, either because one 
isoform is always present or is it always missing, or because of a change in the ratio between 
the two isoforms. Disruption of the levels of isoforms could lead to changes in filamin B 
binding to its interacting partners, or changes to how filamin B crosslinks the cytoskeleton 
and protects the cells against mechanical strain reference.  
 
As filamin B is observed to have multiple syndromes depending on where the mutation occurs 
it is helpful to look at how it functions, such as its role as an actin-binding protein and whether 
or not if cell signalling could be affected and if so, to what extent. In Larsen syndrome, the 
mutations are not exclusively in the ABD and therefore, do not appear to be as severe as seen 
in atelosteogenesis because there is still a degree of functionality. Moreover, we can 
hypothesise that it affects the hinge-1 domain. Therefore, it must have an effect on the actin 
network to produce a phenotype as seen in other filamin related syndromes.  
 
The research I have conducted  has highlighted that tight control of hinge-exclusion is 
required during the development of ligaments (E15.5-E16.5). Therefore if the hinge is either 
unable to be excluded or always excluded, this could affect protein function and result in 
Larsen syndrome. If hinge-1 was to be permanently excluded the effects could produce a 
protein that has an active function (resulting in a gain of function phenotype) such as an 
increase in binding capability that is usually tightly controlled, eventually producing unstable 
joints through an overactive bundling of actin fibres disrupting the actin network.  
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Alternatively, the hinge could become permanently included and the mutation might lead to 
an alteration in actin-binding (similar to that seen in AOI) giving rise to an overactive protein 
that could produce the effects seen or it might alter cell signalling. It is also worth noting that 
the variants noted in figure 1.3  could also just render the hinge-1 non-functional so to as 
have lost its flexibility in a way that could give filamin B it is gain of function, deleterious 
effects.  
 
If we can predict the effects of the hinge-1 adjacent variants then we can begin to speculate 
how this might lead to the developmental phenotypes seen in Larsen syndrome. Although 
this may help in understanding the underlying pathological mechanism it still remains 
questionable how hinge-1 adjacent variants can produce a more severe phenotype. If the 
puncta are involved in the strengthening of the ligaments and are now absent then we may 





In this project the use of the two filamin mouse models has provided an insightful and 
valuable analysis of where both forms of hinge-1 included and hinge-1 excluded filamin B are 
found during development. It has been shown that between mouse embryonic time points 
E15.5 and E16.5 is the critical point at which ligaments form in the knee joint. In addition to 
this red puncta indicating hinge-1 excluded filamin B is present within the joint capsule 
between the forming femur and tibia at E15.5. This is immediately prior to the formation of 
the tangible ligaments and suggests a possible link to their importance in normal 
development. With this in mind, we can begin to hypothesise that the variants seen to 
surround the hinge-1 exon result in Larsen could be related to these red puncta that 
immediately precede formation of the ligaments. Therefore this may be affecting the 
ligament stability and the overall integrity of the joint and leading to a heightened possibility 
of dislocations. This is further supported when considering that that hip joint is also seen to 
dislocate often in Larsen and at the same time point as the knee ligaments are seen to have 
the red puncta, so too is the hip joint. Over all these puncta were exclusively confined to the 
joint spaces within all developing legs examined at E15.5. In further studies, I hypothesise that 
these puncta would also be observed in elbow and other developing joint spaces. 
 
Both forms of tagged filamin B were present at all time points and appear to drop in 
expression at P5. There is an increase in observed fluorescence at P2 in the ligaments, 
following the E16.5 observation. It has been observed that the filamin B tends to be present 
toward the edge of the cell, closer to the membrane and so too are the red puncta observed 
here. This finding was supported by the detection of filamin in the cleavage furrow which also 
validated the model. In future research, higher resolution imaging and immune co-
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